Personensuche
Personensuche
Es wurde 1 Person gefunden.
Telefon
Webseite
Funktionen
-
Institutsdirektor/in, Klinik für Neurologie
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Andexanet alfa in patients with factor Xa inhibitor-associated intracranial hemorrhage : The prospective observational multicenter ASTRO-DE studyIn: International Journal of Stroke, Jg. 20, 2025, Nr. 7, S. 831 – 842DOI (Open Access)
-
Asian-Pacific Expert Opinion on Patent Foramen Ovale Closure : Review of New Evidence and Focused UpdateIn: Journal of Stroke, Jg. 27, 2025, Nr. 3, S. 329 – 337DOI (Open Access)
-
Atogepant : Oraler CGRP-Antagonist zur MigräneprophylaxeIn: Arzneimitteltherapie (AMT), Jg. 43, 2025, Nr. 1, S. 14 – 24
-
Atogepant from an expert's point of viewIn: Arzneimitteltherapie (AMT), Jg. 43, 2025, Nr. 1, S. 25 – 26
-
Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke : Insights From the GLORIA-AF Registry (Phase 2)In: Pacing and Clinical Electrophysiology: PACE, Jg. 48, 2025, Nr. 1, S. 42 – 49
-
Cognitive deficits in patients with peripheral vestibular dysfunctionIn: European Journal of Neurology, Jg. 32, 2025, Nr. 1, e15907DOI (Open Access)
-
Disrupting Migraine Dynamics : A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody TherapiesIn: Neurology and Therapy, Jg. 14, 2025, Nr. 4, S. 1185 – 1196DOI (Open Access)
-
Dopamine and prolactin in migraine : Mechanisms and potential therapeutic targetsIn: Journal of Neuroendocrinology, 2025, in pressDOI (Open Access)
-
Edukation bei chronischen Kopfschmerzen durch Übergebrauch von Schmerz- und Migränemitteln : Ergebnisse einer systematischen LiteraturrechercheIn: Der Schmerz, 2025, in pressDOI (Open Access)
-
Efficacy and safety of kinetic oscillation stimulation in the nasal cavity for the treatment of acute migraine attacks : A randomized, placebo-controlled, double-blind investigationIn: Cephalalgia Reports, Jg. 8, 2025, 1-8 SeitenDOI, Online Volltext (Open Access)
-
Evidence-based guidelines for the pharmacological treatment of migraineIn: Cephalalgia, Jg. 45, 2025, Nr. 4DOI (Open Access)
-
Evidence-based guidelines for the pharmacological treatment of migraine, summary versionIn: Cephalalgia, Jg. 45, 2025, Nr. 4DOI (Open Access)
-
Guidelines of the International Headache Society for Real-World Evidence studies in migraine and cluster headacheIn: Cephalalgia, Jg. 45, 2025, Nr. 3DOI (Open Access)
-
International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraineIn: Cephalalgia, Jg. 45, 2025, Nr. 10DOI (Open Access)
-
Koffeinhaltige Analgetika bei akuten Kopfschmerzen : Rezeptfreie Behandlung ohne GefahrIn: MMW - Fortschritte der Medizin, Jg. 167, 2025, Nr. 5, S. 69 – 71
-
Neue Studiendaten zur Primär- und Sekundärprävention des SchlaganfallsIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 93, 2025, Nr. 03, S. 104 – 115
-
Neue evidenzbasierte Leitlinien der Internationalen Kopfschmerzgesellschaft für die pharmakologische Behandlung der MigräneIn: Psychopharmakotherapie, Jg. 32, 2025, Nr. 4, S. 148 – 151
-
Neues über die Therapie des akuten SchlaganfallsIn: Nervenheilkunde, Jg. 44, 2025, Nr. 5, S. 327 – 339
-
Prior Anticoagulation and Risk of Hemorrhagic Transformation in Acute Stroke : A Post Hoc Analysis of the PRODAST StudyIn: Journal of the American Heart Association, Jg. 14, 2025, Nr. 3, e037014DOI (Open Access)
-
Prävalenz und Inzidenz von Migräne in der Hausarztpraxis : Eine Befragung von Hausärzten in Nordrhein-WestfalenIn: MMW - Fortschritte der Medizin, Jg. 167, 2025, Nr. Suppl. 4, S. 3 – 10
-
Setting higher standards for migraine prevention : A position statement of the International Headache SocietyIn: Cephalalgia, Jg. 45, 2025, Nr. 2DOI (Open Access)
-
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumabIn: The Journal of Headache and Pain, Jg. 26, 2025, Nr. 1, 26DOI (Open Access)
-
25 Migräne-Akuttherapien im VergleichIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 10, S. 26
-
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack : The NOAH-AFNET 6 TrialIn: Journal of the American Heart Association, Jg. 13, 2024, Nr. 17, e036429
-
Bei vorherigem Versagen oraler Behandlung : Antikörper schlägt orale Mittel bei MigräneprophylaxeIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 21, S. 33
-
Comparative effects of drug interventions for the acute management of migraine episodes in adults : systematic review and network meta-analysisIn: BMJ: British Medical Journal, Jg. 386, 2024, e080107DOI (Open Access)
-
Corona-Impfung kann Long Covid abwendenIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 19, S. 27
-
Depressivität bei Migräne wird gebessertIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 12, S. 26
-
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting : The PRODAST studyIn: European Stroke Journal, Jg. 9, 2024, Nr. 3, S. 696 – 703DOI (Open Access)
-
Expert opinion on design and endpoints for studies on catheter ablation of atrial fibrillationIn: Journal of Cardiovascular Electrophysiology (JCE), Jg. 35, 2024, Nr. 11, S. 2182 – 2201DOI (Open Access)
-
Gibt es überhaupt Triptan-Nonresponder?In: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 6, S. 26
-
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injuryIn: Cephalalgia, Jg. 44, 2024, Nr. 3DOI (Open Access)
-
Indobufen nicht besser als ASS nach ApoplexIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 8, S. 28
-
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of MigraineIn: Cephalalgia, Jg. 44, 2024, Nr. 9DOI (Open Access)
-
International Headache Society global practice recommendations for the acute pharmacological treatment of migraineIn: Cephalalgia, Jg. 44, 2024, Nr. 8DOI (Open Access)
-
Kann man die „Abnehm-Spritze“ absetzen? : Hohes Risiko der erneuten GewichtszunahmeIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 17, S. 24 – 25
-
Mehr Migränetage nach Covid-ImpfungIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 4, S. 32
-
Migräne : Gepant schon bei ersten Vorboten nehmen?In: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 18, S. 31
-
Mit Long Covid häufen sich psychiatrische Erkrankungen : Retrospektive Analyse legt Assoziation offenIn: MMW - Fortschritte der Medizin, Jg. 166, 2024, Nr. 16, S. 27 – 28
-
Monoklonale Antikörper in der Therapie der Alzheimer-ErkrankungIn: Psychopharmakotherapie, Jg. 31, 2024, Nr. 4, S. 128 – 138
-
New migraine drugs : A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medicationIn: Cephalalgia, Jg. 44, 2024, Nr. 3, S. 1 – 8DOI, Online Volltext (Open Access)
-
Oral anticoagulation in device-detected atrial fibrillation : effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trialIn: European Heart Journal, Jg. 45, 2024, Nr. 19, S. 1733 – 1737DOI (Open Access)
-
Oral anticoagulation in device-detected atrial fibrillation : effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trialIn: European Heart Journal, Jg. 45, 2024, Nr. 19, S. 1733 – 1737DOI (Open Access)
-
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP) : a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialIn: The Lancet Neurology, Jg. 23, 2024, Nr. 1, S. 46 – 59
-
Sumatriptan-naproxen sodium in migraine : A reviewIn: European Journal of Neurology, Jg. 31, 2024, Nr. S2, The Migraine Supplement, e16434DOI (Open Access)
-
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine : An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trialsIn: Headache: The Journal of Head and Face Pain, Jg. 64, 2024, Nr. 7, S. 838 – 848DOI (Open Access)
-
Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study : A case–control studyIn: eClinicalMedicine, Jg. 70, 2024, 102515DOI (Open Access)
-
Akupunktur bei Spannungskopfschmerz?In: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 19, S. 29
-
Alles, was wir über die neuesten Migränetherapeutika wissenIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 20, S. 32 – 33
-
Alopezie durch Anti-CGRP-Substanzen?In: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 16, S. 26
-
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesIn: The New England Journal of Medicine, Jg. 389, 2023, Nr. 13, S. 1167 – 1179DOI, Online Volltext (Open Access)
-
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hIn: European Heart Journal, Jg. 45, 2023, Nr. 10, S. 837 – 849DOI (Open Access)
-
Antidepressiva bei Schmerzen nutzlos?In: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 11, S. 28
-
Chronische RückenschmerzenIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 91, 2023, Nr. 7-8, S. 326 – 339
-
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA : The PRODAST studyIn: International Journal of Stroke, Jg. 18, 2023, Nr. 10, S. 1169 – 1177DOI (Open Access)
-
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke : a subgroup analysis of the EAST-AFNET 4 trialIn: The Lancet Neurology, Jg. 22, 2023, Nr. 1, S. 45 – 54
-
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention : GRADE tables elaborated by the ad hoc working group of the International Headache SocietyIn: Cephalalgia, Jg. 43, 2023, Nr. 10DOI (Open Access)
-
Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache : Subgroup analysis of the randomized PROMISE-2 trialIn: Headache: The Journal of Head and Face Pain, Jg. 63, 2023, Nr. 2, S. 264 – 274DOI (Open Access)
-
Erratum zu : Schmerzmittelgebrauch in Deutschland: Eine Erhebung über die Jahre 2008 bis 2019In: Der Schmerz, Jg. 37, 2023, Nr. 6, S. 466 – 467DOI (Open Access)
-
Erratum zu : Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen MigräneprophylaxeIn: Der Schmerz, Jg. 37, 2023, Nr. 1, S. 17 – 18DOI (Open Access)
-
Erratum zu: Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen MigräneprophylaxeIn: Der Nervenarzt, Jg. 94, 2023, Nr. 4, S. 318 – 319DOI (Open Access)
-
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition : An experience-based updateIn: Cephalalgia, Jg. 43, 2023, Nr. 5, 3331024231178239DOI (Open Access)
-
Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial HypertensionIn: Cephalalgia, Jg. 43, 2023, Nr. 8, S. 1 – 25DOI (Open Access)
-
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic : A comprehensive reviewIn: Cephalalgia, Jg. 43, 2023, Nr. 1DOI (Open Access)
-
Hypertonie-Behandlung reduziert Risiko für DemenzIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 10, S. 24 – 25
-
Karotisstenose : Es reichen wohl MedikamenteIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 11, S. 27
-
Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen MigräneprophylaxeIn: Der Schmerz, Jg. 37, 2023, Nr. 1, S. 5 – 16DOI (Open Access)
-
Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen MigräneprophylaxeIn: Der Nervenarzt, Jg. 94, 2023, Nr. 4, S. 306 – 317DOI (Open Access)
-
Management of Trigeminal Autonomic Cephalalgias Including Chronic Cluster : A ReviewIn: JAMA Neurology, Jg. 80, 2023, Nr. 3, S. 308 – 319
-
Medikamentose Therapie der akuten Migraneattacke und Prophylaxe der MigraneIn: PZ Prisma, Jg. 30, 2023, Nr. 1, S. 59 – 64
-
Medikamentöse Therapie der akuten Migräneattacke und Prophylaxe der MigräneIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 148, 2023, Nr. 11, S. 678 – 683
-
Migräne : Aktuelle Empfehlungen zur medikamentösen Therapie und Prophylaxe ; Leitlinie der Deutschen Gesellschaft für Neurologie und Deutschen Migräne- und KopfschmerzgesellschaftIn: Arzneimitteltherapie (AMT), Jg. 41, 2023, Nr. 3, S. 50 – 58
-
Migräne-Antikörper lassen Blutdruck steigenIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 4, S. 28
-
Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic strokeIn: International Journal of Stroke, Jg. 18, 2023, Nr. 4, S. 400 – 407DOI (Open Access)
-
Nach Apoplex ist man ohne Statin gefährdetIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 10, S. 26
-
Nervenblockade senkt Zahl der MigränetageIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 12, S. 22
-
Neuer Antikörper bremst kognitiven VerfallIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 8, S. 26 – 27
-
Neues Nasenspray zur Akuttherapie bei MigräneIn: MMW - Fortschritte der Medizin, Jg. 165, 2023, Nr. 1, S. 27
-
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications : A post hoc analysisIn: Headache: The Journal of Head and Face Pain, Jg. 63, 2023, Nr. 10, S. 1351 – 1358DOI (Open Access)
-
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists : The RIC-ICH studyIn: Frontiers in Neurology, Jg. 14, 2023, 1212495DOI, Online Volltext (Open Access)
-
Risk factors for migraine disease progression : a narrative review for a patient-centered approachIn: Journal of Neurology, Jg. 270, 2023, Nr. 12, S. 5692 – 5710DOI (Open Access)
-
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention : A systematic review and network meta-analysisIn: Cephalalgia, Jg. 43, 2023, Nr. 3DOI (Open Access)
-
Schmerzmittelgebrauch in Deutschland : Eine Erhebung über die Jahre 2008 bis 2019In: Der Schmerz, Jg. 37, 2023, Nr. 6, S. 461 – 466DOI (Open Access)
-
Treatment of chronic migraine with Botox (onabotulinumtoxinA) : Development, insights, and impactIn: Medicine, Jg. 102, 2023, Nr. Suppl. 1, e32600DOI (Open Access)
-
A history of International Headache Society grants and their impact on headache careersIn: Cephalalgia, Jg. 42, 2022, Nr. 11-12, S. 1288 – 1293DOI (Open Access)
-
Antithrombotic drugs in secondary stroke prevention: : still some way to goIn: Lancet, Jg. 400, 2022, Nr. 10357, S. 974 – 975
-
Aspirin, paracetamol (acetaminophen) and caffeine for the treatment of acute migraine attacks : A systemic review and meta-analysis of randomized placebo-controlled trialsIn: European Journal of Neurology, Jg. 29, 2022, Nr. 1, S. 350 – 357DOI (Open Access)
-
Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)In: Journal of Stroke, Jg. 24, 2022, Nr. 2, S. 224 – 235DOI (Open Access)
-
Blutverdünnung: Neustart nach HirnblutungIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 16, S. 30 – 31
-
CGRP-targeted drugs for migraine : still many uncertaintiesIn: The Lancet Neurology, Jg. 21, 2022, Nr. 3, S. 209 – 210
-
Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke : A propensity-score matched studyIn: International Journal of Cardiology, Jg. 363, 2022, S. 56 – 63DOI (Open Access)
-
Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease : Systematic Review and Meta-AnalysisIn: Thrombosis and Haemostasis, Jg. 122, 2022, Nr. 11, S. 1879 – 1887
-
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice : GLORIA-AF RegistryIn: Clinical Research in Cardiology, Jg. 111, 2022, Nr. 5, S. 560 – 573DOI (Open Access)
-
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice. GLORIA-AF RegistryIn: Clinical Research in Cardiology, Jg. 111, 2022, Nr. 5, S. 593 – 593DOI (Open Access)
-
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice : Final outcomes from Phase III of the GLORIA-AF registryIn: Clinical Research in Cardiology, Jg. 111, 2022, S. 548 – 559DOI (Open Access)
-
Das am meisten gefährdete Fußballer-Hirn ist das des VerteidigersIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 5, S. 28
-
Diese Komorbiditäten können die Kopfschmerztherapie störenIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 6, S. 24 – 25
-
Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacksIn: Cephalalgia, Jg. 42, 2022, Nr. 1, S. 82 – 85DOI, Online Volltext (Open Access)
-
Establishment of the Heart and Brain Team for Patent Foramen Ovale Closure in Stroke Patients : An Expert OpinionIn: Journal of Stroke, Jg. 24, 2022, Nr. 3, S. 345 – 351DOI (Open Access)
-
Evolution of antithrombotic therapy for patients with atrial fibrillation : The prospective global GLORIA-AF registry programIn: PLoS ONE, Jg. 17, 2022, Nr. 10, e0274237DOI (Open Access)
-
Five-Year Results of Coronary Artery Bypass Grafting With or Without Carotid Endarterectomy in Patients With Asymptomatic Carotid Artery Stenosis: CABACS RCTIn: Stroke, Jg. 53, 2022, Nr. 11, S. 3270 – 3277
-
Glänzende Daten für mRNA-ImpfstoffeIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 1, S. 29DOI, Online Volltext (Open Access)
-
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st editionIn: Cephalalgia, Jg. 42, 2022, Nr. 11-12, S. 1099 – 1115DOI, Online Volltext (Open Access)
-
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster HeadacheIn: Cephalalgia, Jg. 42, 2022, Nr. 14, S. 1450 – 1466DOI (Open Access)
-
Kopfschmerzen durch zu viele Kopfschmerzmittel : Neue Leitlinie zum Medikamenten-Übergebrauch beschreibt Auswege aus dem TeufelskreisIn: Deutsche Apotheker Zeitung, Jg. 162, 2022, Nr. 18, 32(Open Access)
-
Kopfschmerzen durch zu viele KopfschmerzmittelIn: Deutsche Apotheker Zeitung, Jg. 162, 2022, Nr. 8, 32
-
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guidelineIn: Neurological Research and Practice, Jg. 4, 2022, Nr. 1, 37DOI (Open Access)
-
Medikamentöse Behandlung von ClusterkopfschmerzenIn: Arzneimitteltherapie (AMT), Jg. 40, 2022, Nr. 4, S. 99 – 108
-
Nach Schlaganfall schlechte Covid-PrognoseIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 6, S. 29DOI, Online Volltext (Open Access)
-
Nebenwirkungen und Impfkomplikationen nach COVID-19-ImpfungIn: Medizinische Monatsschrift für Pharmazeuten, MMP, Jg. 45, 2022, Nr. 4, S. 140 – 148
-
Neue Arzneimittel zur Therapie der Migräneattacke und zur Prophylaxe der Migräne : Update 2022In: Arzneimitteltherapie (AMT), Jg. 40, 2022, Nr. 6, S. 174 – 188
-
No structural brain alterations in new daily persistent headache : a cross sectional VBM/SBM studyIn: Cephalalgia, Jg. 42, 2022, Nr. 4-5, S. 335 – 344DOI, Online Volltext (Open Access)
-
Optimaler DOAK-Start nach SchlaganfallIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 21-22, S. 30
-
Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source : A systematic review and meta-analysisIn: European Stroke Journal, Jg. 7, 2022, Nr. 2, S. 92 – 98DOI (Open Access)
-
Outcomes of the roll-in cohort of the Amulet IDE trial of left atrial appendage occlusionIn: Heart Rhythm O2, Jg. 3, 2022, Nr. 5, S. 493 – 500DOI (Open Access)
-
Petasites for Migraine Prevention : New Data on Mode of Action, Pharmacology and Safety. A Narrative ReviewIn: Frontiers in Neurology, Jg. 13, 2022, 864689DOI (Open Access)
-
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS TrialIn: Journal of the American Heart Association, Jg. 11, 2022, Nr. 11, e023545DOI (Open Access)
-
Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software applicationIn: Trials, Jg. 23, 2022, Nr. 1, 382DOI, Online Volltext (Open Access)
-
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab : Subanalysis of the PROMISE-2 studyIn: The Journal of Headache and Pain, Jg. 23, 2022, Nr. 1, 115DOI (Open Access)
-
Rationale and design of the AXIOMATIC-SSP phase II trial : Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke PreventionIn: Journal of Stroke and Cerebrovascular Diseases, Jg. 31, 2022, Nr. 10, 106742DOI (Open Access)
-
Recanalization after cerebral venous thrombosis : A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosisIn: International Journal of Stroke, Jg. 17, 2022, Nr. 2, S. 189 – 197DOI, Online Volltext (Open Access)
-
Review and update of the concept of embolic stroke of undetermined sourceIn: Nature Reviews Neurology, Jg. 18, 2022, S. 455 – 465
-
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine : a pooled analysis of phase 3 studiesIn: Cephalalgia, Jg. 42, 2022, Nr. 8, S. 769 – 780DOI (Open Access)
-
Sekundärprophylaxe nach Schlaganfall : Intensivere Senkung des LDL-Cholesterins verspricht besseren GefäßschutzIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 18, S. 28 – 29
-
Stent und Endarteriektomie gleichaufIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 15, S. 28 – 28
-
The main reason for sinus venous thromboses : Severe side effect of viral vector vaccines against COVID-19In: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 6, S. 28DOI, Online Volltext (Open Access)
-
Thrombotische Thrombozytopenie nach Vektorimpfstoff : So wird therapiertIn: MMW - Fortschritte der Medizin, Jg. 164, 2022, Nr. 2, S. 28DOI, Online Volltext (Open Access)
-
Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrumIn: European Heart Journal, Jg. 43, 2022, Nr. 10, S. 940 – 958
-
ASS-Zugabe zur Antikoagulation : kein Benefit, höheres RisikoIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 20, S. 24 – 26
-
Akute Migräneattacke: Leitliniengerecht behandeln und vorbeugenIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 4, S. 38 – 42
-
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE) : A Randomized, Controlled TrialIn: Circulation, Jg. 144, 2021, Nr. 19, S. 1543 – 1552DOI, Online Volltext (Open Access)
-
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation : The GLORIA-AF registryIn: Hellenic Journal of Cardiology, Jg. 62, 2021, Nr. 2, S. 152 – 157DOI (Open Access)
-
Atrial fibrillation and comorbidities : Clinical characteristics and antithrombotic treatment in GLORIA-AFIn: PLoS ONE, Jg. 16, 2021, Nr. 4, S. e0249524DOI (Open Access)
-
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or StrokeIn: Stroke, Jg. 52, 2021, Nr. 10, S. 3258 – 3265DOI (Open Access)
-
COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in GermanyIn: Annals of Neurology, Jg. 90, 2021, Nr. 4, S. 627 – 639DOI (Open Access)
-
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the worldIn: Journal of Arrhythmia, Jg. 37, 2021, Nr. 4, S. 990 – 1006DOI (Open Access)
-
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial FibrillationIn: JACC Cardiovascular Interventions, Jg. 14, 2021, Nr. 1, S. 69 – 78DOI (Open Access)
-
Consecutive headache-free days with OnabotulinumtoxinA treatment in patients with chronic migraine : A pooled PREEMPT analysisIn: Headache: The Journal of Head and Face Pain, Jg. 61, 2021, Nr. Suppl. 1, S. 117
-
Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg : Clinical relevance versus statistical significanceIn: Cephalalgia, Jg. 41, 2021, Nr. 11-12, S. 1276 – 1278DOI, Online Volltext (Open Access)
-
DOAK auch bei Dialyse wirksam und sicherIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 21-22, S. 34 – 35
-
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale : Results From RE-SPECT ESUSIn: Stroke, Jg. 52, 2021, Nr. 3, S. 1065 – 1068DOI (Open Access)
-
Diagnose und Therapie des akuten ischämischen InsultsIn: Herz: Cardiovascular Diseases, Jg. 46, 2021, Nr. 2, S. 195 – 204
-
Diagnosis and management of migraine in ten stepsIn: Nature Reviews Neurology, Jg. 17, 2021, Nr. 8, S. 501 – 514DOI (Open Access)
-
EACVI survey on the management of patients with patent foramen ovale and cryptogenic strokeIn: European Heart Journal - Cardiovascular Imaging, Jg. 22, 2021, Nr. 2, S. 135 – 141DOI (Open Access)
-
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS studyIn: The Journal of Headache and Pain, Jg. 22, 2021, Nr. 1, 68DOI (Open Access)
-
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache : Subgroup analysis of PROMISE-2In: Headache: The Journal of Head and Face Pain, Jg. 61, 2021, Nr. 1, S. 125 – 136DOI (Open Access)
-
Erenumab prevents the occurrence of migraine attacks and not just migraine days : Post-hoc analyses of a phase III studyIn: Cephalalgia, Jg. 41, 2021, Nr. 11-12, S. 1262 – 1267DOI (Open Access)
-
Gegen Fibromyalgie haben wir wenigIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 5, S. 32
-
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraineIn: Cephalalgia, Jg. 41, 2021, Nr. 11-12, S. 1135 – 1151DOI, Online Volltext (Open Access)
-
Headache secondary to cerebrovascular diseaseIn: Cephalalgia, Jg. 41, 2021, Nr. 4, S. 479 – 492DOI, Online Volltext (Open Access)
-
Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache SocietyIn: Cephalalgia, Jg. 41, 2021, Nr. 3, S. 279 – 293DOI (Open Access)
-
Hormonal ContraceptionGuideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry Number 015/015, January 2020)In: Geburtshilfe und Frauenheilkunde, Jg. 81, 2021, Nr. 2, S. 152 – 182DOI (Open Access)
-
Incidence and clinical impact of major bleeding following left atrial appendage occlusion : Insights from the Amplatzer Amulet Observational Post-Market StudyIn: EuroIntervention, Jg. 17, 2021, Nr. 9, S. 774 – 781DOI, Online Volltext (Open Access)
-
Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation : Clinical expert opinion and consensus statement for the Asian-Pacific regionIn: Journal of Interventional Cardiac Electrophysiology, Jg. 61, 2021, Nr. 2, S. 269 – 281
-
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions : the GLORIA-AF studyIn: European Journal of Internal Medicine, Jg. 91, 2021, S. 75 – 80
-
Management von Patienten mit Vorhofflimmern und intrakraniellen Blutungen : Ist eine erneute Antikoagulation möglich? Die ENRICH-AF StudieIn: Neurologie und Rehabilitation, Jg. 27, 2021, Nr. 2, S. 133 – 134DOI (Open Access)
-
Medikamentöse Therapie bei akuten Hirnblutungen unter AntikoagulationIn: Arzneimitteltherapie (AMT), Jg. 39, 2021, Nr. 5, S. 144 – 158
-
Migräne : dramatisch unterversorgt!In: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 7, S. 23
-
Migräne erhöht Demenzrisiko nichtIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 14, S. 28 – 29
-
Mit COVID-19 sind Schlaganfälle häufig - und häufig tödlichIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 17, S. 32DOI, Online Volltext (Open Access)
-
Mit Ernährung vor erneutem Schlaganfall schützenIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 11, S. 24 – 25
-
Neurologische Aspekte der Coronavirus- InfektionIn: MMW - Fortschritte der Medizin, Jg. 163, 2021, Nr. 1, S. 40 – 41DOI, Online Volltext (Open Access)
-
Onset of action in placebo-controlled migraine attacks trials : A literature review and recommendationIn: Cephalalgia, Jg. 41, 2021, Nr. 2, S. 148 – 155DOI, Online Volltext (Open Access)
-
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trialIn: EP Europace, Jg. 23, 2021, Nr. 1, S. 65 – 72DOI (Open Access)
-
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source : An Analysis of the RE-SPECT ESUS TrialIn: Circulation, Jg. 144, 2021, Nr. 22, S. 1738 – 1746DOI (Open Access)
-
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheIn: Headache: The Journal of Head and Face Pain, Jg. 61, 2021, Nr. 9, S. 1421 – 1431DOI (Open Access)
-
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) StudyIn: European Stroke Journal, Jg. 6, 2021, Nr. 4, S. 438 – 444DOI (Open Access)
-
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache : A multicentre, double-blind, randomised controlled trialIn: The Lancet Neurology, Jg. 20, 2021, Nr. 1, S. 29 – 37
-
Sekundärprävention nach TIA oder ischämischem SchlaganfallIn: Herz: Cardiovascular Diseases, Jg. 46, 2021, S. 293 – 302
-
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trialsIn: BMC Medical Research Methodology, Jg. 21, 2021, Nr. 1, 218DOI (Open Access)
-
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income levelIn: Heart, Jg. 107, 2021, Nr. 4, S. 282 – 289DOI (Open Access)
-
ASS ist P2Y₁₂-Hemmern ebenbürtigIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. S3, S. 28
-
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 casesIn: International Journal of Stroke, Jg. 15, 2020, Nr. 6, S. 609 – 618
-
Antithrombotic Treatment of Embolic Stroke of Undetermined Source : RE-SPECT ESUS Elderly and Renally Impaired SubgroupsIn: Stroke, Jg. 51, 2020, Nr. 6, S. 1758 – 1765DOI (Open Access)
-
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age : the GLORIA-AF registry programmeIn: EP Europace, Jg. 22, 2020, Nr. 1, S. 47 – 57DOI (Open Access)
-
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment : A Pooled PREEMPT AnalysisIn: Pain and Therapy, 2020DOI (Open Access)
-
COVID-19 erhöht Schlaganfallrisiko : Coronavirus-PandemieIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. 14, S. 29DOI, Online Volltext (Open Access)
-
COVID-19: Angriff auf Psyche : Corona-PandemieIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. 16, S. 32DOI, Online Volltext (Open Access)
-
Cardiovascular care of patients with stroke and high risk of stroke : The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round TableIn: European Journal of Preventive Cardiology, Jg. 27, 2020, Nr. 7, S. 682 – 692DOI, Online Volltext (Open Access)
-
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation : GLORIA-AFIn: ESC Heart Failure, Jg. 7, 2020, Nr. 5, S. 2679 – 2689DOI (Open Access)
-
Closure of the patent foramen ovale in patients with embolic stroke of undetermined source : A clinical expert opinion and consensus statement for the Asian-Pacific regionIn: International Journal of Stroke, Jg. 15, 2020, Nr. 9, S. 937 – 944
-
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF RegistryIn: The American Journal of Cardiology, Jg. 125, 2020, Nr. 3, S. 383 – 391DOI (Open Access)
-
Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source : Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled TrialIn: Circulation Journal, Jg. 84, 2020, Nr. 12, S. 2286 – 2295DOI (Open Access)
-
Dural Arteriovenous Fistulae After Cerebral Venous ThrombosisIn: Stroke, Jg. 51, 2020, Nr. 11, S. 3344 – 3347DOI (Open Access)
-
European Academy of Neurology guideline on the management of medication-overuse headacheIn: European Journal of Neurology, Jg. 27, 2020, Nr. 7, S. 1102 – 1116DOI (Open Access)
-
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adultsIn: Cephalalgia, Jg. 40, 2020, Nr. 10, S. 1026 – 1044DOI, Online Volltext (Open Access)
-
Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? : Laying the ground for the 4th editionIn: Cephalalgia, Jg. 40, 2020, Nr. 8, S. 778 – 787DOI, Online Volltext (Open Access)
-
Left atrial appendage occlusion with the AmplatzerTM AmuletTM device : Full results of the prospective global observational studyIn: European Heart Journal, Jg. 41, 2020, Nr. 28, S. 2894 – 2901DOI, Online Volltext (Open Access)
-
Leitlinien für Diagnostik und Therapie in der Neurologie : Prophylaxe der Migräne mit monoklonalen Antikörpern gegen CGRP oder den CGRP-RezeptorIn: Arzneimitteltherapie (AMT), Jg. 38, 2020, Nr. 3, S. 69 – 92
-
Migräne mit Aura steigert Gefäßrisiko deutlichIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. 19, S. 30
-
Mit Ernährung Apoplexe vermeidenIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. 20, S. 33
-
Non-invasive vagus nerve stimulation for primary headache : A clinical updateIn: Cephalalgia, Jg. 40, 2020, Nr. 12, S. 1370 – 1384DOI (Open Access)
-
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillationIn: European Heart Journal Supplements, Jg. 22, 2020, Nr. Suppl. I, S. I13 – I21DOI (Open Access)
-
Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillationIn: European Heart Journal Supplements, Jg. 22, 2020, Nr. Suppl. I, S. I13 – I21DOI (Open Access)
-
Pain freedom after 2 hours should be the primary outcome in controlled trials treating migraine attacksIn: Cephalalgia, Jg. 40, 2020, Nr. 12, S. 1331 – 1335DOI, Online Volltext (Open Access)
-
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillationIn: Future Neurology, Jg. 15, 2020, Nr. 3, S. FNL48DOI (Open Access)
-
Persistence with Anticoagulation for Atrial Fibrillation : Report from the GLORIA-AF Phase III 1-Year Follow-upIn: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 6, 1969DOI (Open Access)
-
Prevencion del stroke en fibrilacion auricular : Hallazgos del registro gloria-afIn: Revista Argentina de Cardiologia, Jg. 88, 2020, Nr. 4, S. 279 – 281
-
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus SeminarIn: Journal of the American College of Cardiology (JACC), Jg. 75, 2020, Nr. 15, S. 1804 – 1818DOI (Open Access)
-
Primärprävention des SchlaganfallsIn: Nervenheilkunde, Jg. 39, 2020, Nr. 10, S. 636 – 643DOI (Open Access)
-
Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention : A mini-reviewIn: Cephalalgia, Jg. 40, 2020, Nr. 1, S. 122 – 126DOI, Online Volltext (Open Access)
-
Prophylaxe der Migräne mit monoklonalen Antikörpern gegen CGRP oder den CGRP-RezeptorIn: Nervenheilkunde, Jg. 39, 2020, Nr. 1, S. S2 – S24
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke : A multicentre, double-blind, randomised, placebo-controlled trialIn: The Lancet Neurology, Jg. 19, 2020, Nr. 3, S. 226 – 233DOI, Online Volltext (Open Access)
-
Statine schützen vor ischämischem Schlaganfall : Primär- und SekundärpräventionIn: MMW - Fortschritte der Medizin, Jg. 162, 2020, Nr. 18, S. 27 – 28
-
Stroke prevention in atrial fibrillation changes after dabigatran availability in China : The GLORIA-AF registryIn: Journal of Arrhythmia, Jg. 36, 2020, Nr. 3, S. 408 – 416DOI (Open Access)
-
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic MigraineIn: Pain and Therapy, 2020DOI (Open Access)
-
The Risks or Lack Thereof of Migraine Treatments in Vascular DiseaseIn: Headache: The Journal of Head and Face Pain, Jg. 60, 2020, Nr. 3, S. 649 – 653DOI (Open Access)
-
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% responseIn: Cephalalgia, Jg. 40, 2020, Nr. 1, S. 28 – 38DOI, Online Volltext (Open Access)
-
Vergangenheit und Zukunft des ESUS-KonzeptsIn: Der Nervenarzt, Jg. 91, 2020, S. 511 – 517DOI (Open Access)
-
115 : Economic burden among migraine patients : United Kingdom PerspectiveIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 90, 2019, Nr. 12, S. e8
-
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adultsIn: Cephalalgia, Jg. 39, 2019, Nr. 8, S. 1058 – 1066DOI, Online Volltext (Open Access)
-
An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B) : An international, randomised, double-blind, sham-controlled, pivotal trialIn: Lancet, Jg. 394, 2019, Nr. 10194, S. 219 – 229
-
Andexanet alfa : From the experts' point of viewIn: Arzneimitteltherapie (AMT), Jg. 37, 2019, Nr. 4, S. 128 – 129
-
Antiplatelet Therapy After Noncardioembolic Stroke : An Individual Patient Data Network Meta-AnalysisIn: Stroke, Jg. 50, 2019, Nr. 7, S. 1812 – 1818DOI (Open Access)
-
Antithrombotic therapy to prevent recurrent strokes in ischemic cerebrovascular disease : JACC scientific expert panelIn: Journal of the American College of Cardiology (JACC), Jg. 74, 2019, Nr. 6, S. 786 – 803DOI, Online Volltext (Open Access)
-
Atrial Fibrillation and Cognitive Function : JACC Review Topic of the WeekIn: Journal of the American College of Cardiology (JACC), Jg. 73, 2019, Nr. 5, S. 612 – 619DOI (Open Access)
-
CGRP antibodies for migraine prevention — new kids on the blockIn: Nature Reviews Neurology, Jg. 15, 2019, Nr. 3, S. 129 – 130
-
Chininsulfat in der Therapie nächtlicher Wadenkrämpfe : Verträglichkeit, Compliance, Lebensqualität und Einfluss auf Symptome: Eine multizentrische nichtinterventionelle Studie (NIS) bei ErwachsenenIn: MMW - Fortschritte der Medizin, Jg. 161, 2019, Nr. Suppl. 6, S. 24 – 31
-
Comment on: “Phytomedicines in the Treatment of Migraine”In: CNS Drugs, Jg. 33, 2019, Nr. 6, S. 615 – 615DOI (Open Access)
-
Dabigatran for prevention of stroke after embolic stroke of undetermined sourceIn: The New England Journal of Medicine, Jg. 380, 2019, Nr. 20, S. 1906 – 1917DOI (Open Access)
-
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT dataIn: Cephalalgia, Jg. 39, 2019, Nr. 8, S. 945 – 956DOI, Online Volltext (Open Access)
-
Erenumab in chronic migraine with medication overuse : Subgroup analysis of a randomized trialIn: Neurology, Jg. 92, 2019, Nr. 20, S. e2309 – e2320DOI (Open Access)
-
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS) : a randomised, double-blind, placebo-controlled, phase 3b trialIn: Lancet, Jg. 394, 2019, Nr. 10203, S. 1030 – 1040
-
Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute StrokeIn: Stroke, Jg. 50, 2019, S. 690 – 696DOI, Online Volltext (Open Access)
-
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth editionIn: Cephalalgia, Jg. 39, 2019, Nr. 6, S. 687 – 710DOI (Open Access)
-
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st editionIn: Cephalalgia, Jg. 39, 2019, Nr. 7, S. 803 – 816DOI, Online Volltext (Open Access)
-
IHC 2019 Late Breaking Author IndexIn: Cephalalgia, Jg. 39, 2019, Nr. 1, S. 428 – 432DOI (Open Access)
-
Implant for augmentation of Cerebral blood flow trial-1 (IMPact-1) : A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic strokeIn: PLoS ONE, Jg. 14, 2019, Nr. 7, S. 0217472DOI (Open Access)
-
Neues in der Prophylaxe und Therapie des SchlaganfallsIn: Arzneimitteltherapie (AMT), Jg. 37, 2019, Nr. 12, S. 439 – 447
-
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine : The multicentre, double-blind, randomised, sham-controlled PREMIUM trialIn: Cephalalgia, Jg. 39, 2019, Nr. 12, S. 1475 – 1487DOI (Open Access)
-
Optimale Blutdruckeinstellung bei Patienten mit akutem ischämischem Schlaganfall : ENCHANTED-StudieIn: Der Internist, Jg. 60, 2019, Nr. 10, S. 1118 – 1120
-
Pathophysiology, prevention, and treatment of medication overuse headacheIn: The Lancet Neurology, Jg. 18, 2019, Nr. 9, S. 891 – 902
-
Rationale and design for AMPLATZER™ amulet™ left atrial appendage Occluder IDE randomized controlled trial (amulet IDE trial)In: American Heart Journal, Jg. 211, 2019, S. 45 – 53
-
Real-world comparison of in-hospital Reveal LINQ insertable cardiac monitor insertion inside and outside of the cardiac catheterization or electrophysiology laboratoryIn: American Heart Journal, Jg. 207, 2019, S. 76 – 82
-
Results and lessons learnt from a randomized controlled trial : Prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)In: Trials, Jg. 20, 2019, Nr. 1, S. 813DOI, Online Volltext (Open Access)
-
Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients with Cerebral Venous Thrombosis : A Randomized Clinical TrialIn: JAMA Neurology, Jg. 76, 2019, Nr. 12, S. 1457 – 1465DOI (Open Access)
-
Safety and effectiveness of dabigatran at 2 years : Final outcomes from Phase II of the GLORIA-AF registry programIn: American Heart Journal, Jg. 218, 2019, S. 123 – 127
-
Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow : A Randomized, Sham-Controlled TrialIn: Stroke, Jg. 50, 2019, Nr. 8, S. 2108 – 2117DOI (Open Access)
-
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease : Section V—Special SituationsIn: Thrombosis and Haemostasis, Jg. 119, 2019, Nr. 01, S. 014 – 038DOI (Open Access)
-
Uninterrupted edoxaban vs. Vitamin K antagonists for ablation of atrial fibrillation: The ELIMINATE-AF trialIn: European Heart Journal, Jg. 40, 2019, Nr. 36, S. 3013 – 3021DOI (Open Access)
-
Verschluss des offenen Foramen ovale (PFO) beim kryptogenen SchlaganfallIn: Herz: Cardiovascular Diseases, Jg. 44, 2019, Nr. 4, S. 304 – 309
-
Chronische Kopfschmerzen durch Übergebrauch von Schmerz-und MigränemittelnIn: Deutsches Ärzteblatt International, Jg. 115, 2018, Nr. 22, S. 365 – 370DOI (Open Access)
-
Closure of patent foramen ovale and cryptogenic stroke : Unresolved issuesIn: Current Neurology and Neuroscience Reports, Jg. 18, 2018, Nr. 12, 92
-
Expert opinion paper on atrial fibrillation detection after ischemic strokeIn: Clinical Research in Cardiology, Jg. 107, 2018, Nr. 10, S. 871 – 880
-
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation : The GLORIA-AF Registry ProgramIn: The American Journal of Medicine, Jg. 131, 2018, Nr. 8, S. 945 – 955.e3DOI, Online Volltext (Open Access)
-
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adultsIn: Cephalalgia, Jg. 38, 2018, Nr. 5, S. 815 – 832DOI (Open Access)
-
Interventioneller PFO-Verschluss : Konsensuspapier der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung (DGK) gemeinsam mit der Deutschen Gesellschaft für Neurologie (DGN) und der Deutschen Schlaganfallgesellschaft (DSG)In: Der Kardiologe, Jg. 12, 2018, Nr. 6, S. 415 – 423
-
Kryptogener Schlaganfall und offenes Foramen ovale : S2e-LeitlinieIn: Der Nervenarzt, Jg. 89, 2018, Nr. 10, S. 1143 – 1153
-
Left atrial appendage occlusion with the AMPLATZER Amulet device : One-year follow-up from the prospective global Amulet observational registryIn: EuroIntervention, Jg. 14, 2018, Nr. 5, S. e590 – e597
-
Migraine mimicking stroke : What to do?In: Cephalalgia, Jg. 38, 2018, Nr. 14, S. 1995 – 1997DOI (Open Access)
-
My Migraine Voice survey : a global study of disease burden among individuals with migraine for whom preventive treatments have failedIn: The Journal of Headache and Pain, Jg. 19, 2018, S. 115DOI (Open Access)
-
Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache : A randomized, double-blind, sham-controlled ACT2 studyIn: Cephalalgia, Jg. 38, 2018, Nr. 5, S. 959 – 969DOI (Open Access)
-
Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary strokeIn: Expert Opinion on Pharmacotherapy, Jg. 19, 2018, Nr. 14, S. 1597 – 1602
-
Polarity-specific Modulation of Central Pain Processing by Transcranial Direct Current StimulationIn: Neurology, Jg. 90, 2018, Nr. Suppl. 15, S. P2.100
-
Polarity-specific modulation of pain processing by transcranial direct current stimulation – a blinded longitudinal fMRI studyIn: The Journal of Headache and Pain, Jg. 19, 2018, Nr. 1, S. 99DOI (Open Access)
-
Positionspapier zur Detektion von Vorhofflimmern nach ischämischem Schlaganfall : Arbeitsgemeinschaft Herz und Hirn der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung e.V. (DGK) und der Deutschen Schlaganfall-Gesellschaft e.V. (DSG)In: Aktuelle Neurologie, Jg. 45, 2018, Nr. 2, S. 93 – 106DOI (Open Access)
-
Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE) : an international observational studyIn: Lancet, Jg. 391, 2018, Nr. 10134, S. 2019 – 2027DOI, Online Volltext (Open Access)
-
Preventing dementia beyond treating hypertensionIn: European Heart Journal, Jg. 39, 2018, Nr. 33, S. 3126 – 3127
-
Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device : Perspective of available/ongoing registries of catheter-based LAA occlusionIn: Catheterization and Cardiovascular Interventions, Jg. 91, 2018, Nr. 3, S. 540 – 547
-
Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosisIn: International Journal of Stroke, Jg. 13, 2018, Nr. 7, S. 766 – 770
-
The role of cardiologists in stroke prevention and treatment : Position paper of the European Society of Cardiology Council on StrokeIn: European Heart Journal, Jg. 39, 2018, Nr. 17, S. 1567 – 1573
-
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation : global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registryIn: American Heart Journal, Jg. 198, 2018, S. 55 – 63DOI, Online Volltext (Open Access)
-
Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation : Rationale and design of the ELIMINATE-AF studyIn: Clinical Cardiology, Jg. 41, 2018, Nr. 4, S. 440 – 449DOI (Open Access)
-
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany : A national case collectionIn: International Journal of Stroke, Jg. 12, 2017, Nr. 4, S. 383 – 391DOI (Open Access)
-
Atrial fibrillation and microbleedsIn: Stroke, Jg. 48, 2017, Nr. 10, S. 2660 – 2664DOI (Open Access)
-
Atrial high-rate episodes and stroke preventionIn: EP Europace, Jg. 19, 2017, Nr. 2, S. 169 – 179DOI (Open Access)
-
Bedeutung des Neuropeptids CGRP bei primären Kopfschmerzen : CGRP-Antikörper zur MigräneprophylaxeIn: Psychopharmakotherapie, Jg. 24, 2017, Nr. 2, S. 44 – 55
-
Bedeutung des Neuropeptids CGRP bei primären Kopfschmerzen : CGRP-Antikörper zur MigräneprophylaxeIn: Arzneimitteltherapie (AMT), Jg. 35, 2017, Nr. 7-8, S. 272 – 281
-
Caffeine in the management of patients with headacheIn: The Journal of Headache and Pain, Jg. 18, 2017, S. 107DOI (Open Access)
-
Cerebral gray matter changes in persistent postural perceptual dizzinessIn: Journal of Psychosomatic Research, Jg. 103, 2017, S. 95 – 101
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation : Part 2In: European Heart Journal, Jg. 38, 2017, Nr. 12, S. 860 – 868
-
Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: Part 1In: European Heart Journal, Jg. 38, 2017, Nr. 12, S. 852 – 859
-
Correlation between clinical outcomes and baseline CT and CT angiographic findings in the SWIFT PRIME trialIn: American Journal of Neuroradiology: AJNR / American Society of Neuroradiology (Hrsg.), Jg. 38, 2017, Nr. 12, S. 2270 – 2276
-
Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke : Results from the SWIFT-PRIME Trial (Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)In: Stroke, Jg. 48, 2017, Nr. 2, S. 379 – 387DOI (Open Access)
-
Die Sicht des Neurologen : Gerinnungshemmung bei betagten PatientenIn: MMW - Fortschritte der Medizin, Jg. 159, 2017, Nr. 3, S. 44 – 46
-
Differenzialtherapie von KopfschmerzenIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 142, 2017, Nr. 6, S. 418 – 426
-
Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache : a prospective observational studyIn: Cephalalgia, Jg. 37, 2017, Nr. 9, S. 873 – 880
-
Empagliflozin and Cerebrovascular Events in Patients with Type 2 Diabetes Mellitus at High Cardiovascular RiskIn: Stroke, Jg. 48, 2017, Nr. 5, S. 1218 – 1225DOI (Open Access)
-
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapyIn: Blood, Jg. 129, 2017, Nr. 22, S. 2980 – 2987DOI (Open Access)
-
Kommentar zu den 2016 Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management von VorhofflimmernIn: Der Kardiologe, Jg. 11, 2017, Nr. 3, S. 193 – 204
-
NOAK - Gerinnungsmanagement bei schweren BlutungenIn: Arzneimitteltherapie (AMT), Jg. 35, 2017, Nr. 9, S. 321 – 327
-
Neues bei KopfschmerzenIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 85, 2017, Nr. 6, S. 352 – 365
-
No Pattern Alteration in Single Nocturnal Melatonin Secretion in Patients With Hypnic Headache : A Case–Control StudyIn: Headache: The Journal of Head and Face Pain, Jg. 57, 2017, Nr. 4, S. 648 – 653
-
Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack : an updated systematic review and meta-analysis of randomized controlled trialsIn: International Journal of Stroke, Jg. 12, 2017, Nr. 6, S. 589 – 596
-
Off-label use of direct oral anticoagulants in intracerebral hemorrhage patients with prosthetic valvesIn: Stroke, Jg. 48, 2017, Nr. 11, S. 3183 – 3186
-
Percutaneous left atrial appendage occlusion : The Munich consensus document on definitions, endpoints, and data collection requirements for clinical studiesIn: EP Europace, Jg. 19, 2017, Nr. 1, S. 4 – 15DOI (Open Access)
-
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial FibrillationIn: Journal of the American College of Cardiology (JACC), Jg. 70, 2017, Nr. 13, S. 1573 – 1583DOI (Open Access)
-
Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution : Impact of Migraine-Associated Nausea and Prior Triptan Use on EfficacyIn: Headache: The Journal of Head and Face Pain, Jg. 57, 2017, Nr. 5, S. 756 – 765DOI (Open Access)
-
Predicting major bleeding in patients with noncardioembolic stroke on antiplateletsIn: Neurology, Jg. 89, 2017, Nr. 9, S. 936 – 943
-
Preventing major gastrointestinal bleeding in elderly patientsIn: Lancet, Jg. 390, 2017, Nr. 10093, S. 435 – 437DOI (Open Access)
-
Probing oral anticoagulation in patients with atrial high rate episodes : Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.In: American Heart Journal, Jg. 190, 2017, S. 12 – 18DOI (Open Access)
-
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation : Insights from the GLORIA-AF Phase II RegistryIn: Thrombosis and Haemostasis, Jg. 117, 2017, Nr. 12, S. 2376 – 2388DOI, Online Volltext (Open Access)
-
Response by Zinman et al to Letter Regarding Article, "Empagliflozin and Cerebrovascular Events in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk"In: Stroke, Jg. 48, 2017, Nr. 9, S. e256 – e257
-
Safety of Simultaneous Coronary Artery Bypass Grafting and Carotid Endarterectomy Versus Isolated Coronary Artery Bypass Grafting : A Randomized Clinical TrialIn: Stroke, Jg. 48, 2017, Nr. 10, S. 2769 – 2775DOI (Open Access)
-
Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)In: Current Neurology and Neuroscience Reports, Jg. 17, 2017, Nr. 9, 064
-
Short Latency Gray Matter Changes in Voxel-Based Morphometry following High Frequent Visual StimulationIn: Neural Plasticity, Jg. 2017, 2017, S. 1397801DOI (Open Access)
-
The Intracranial-B₂LEED₃S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients under Antiplatelet TreatmentIn: Cerebrovascular Diseases, Jg. 43, 2017, Nr. 3-4, S. 145 – 151DOI (Open Access)
-
The cause of stroke matters for secondary preventionIn: The Lancet Neurology, Jg. 16, 2017, Nr. 4, S. 256 – 257
-
The changing landscape for stroke prevention in AF : findings from the GLORIA-AF registry phase 2In: Journal of the American College of Cardiology (JACC), Jg. 69, 2017, Nr. 7, S. 777 – 785DOI (Open Access)
-
Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke : Expert opinionIn: International Journal of Stroke, Jg. 12, 2017, Nr. 1, S. 9 – 12
-
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation : Executive summaryIn: European Heart Journal, Jg. 38, 2017, Nr. 27, S. 2137 – 2149
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: European Heart Journal, Jg. 37, 2016, Nr. 38, S. 2893 – 2962
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: EP Europace, Jg. 18, 2016, Nr. 11, S. 1609 – 1678
-
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSIn: European Journal of Cardio-Thoracic Surgery, Jg. 50, 2016, Nr. 5, S. e1 – e88
-
Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke : Results from the SWIFT PRIME Randomized Controlled TrialIn: Radiology, Jg. 279, 2016, Nr. 3, S. 888 – 897
-
Antikoagulation bei Patienten mit gastrointestinaler BlutungIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 6, S. E37
-
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants : the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohortIn: EP Europace, Jg. 18, 2016, Nr. 9, S. 1308 – 1318DOI (Open Access)
-
Apixaban vs. Warfarin bei Patienten mit Vorhofflimmern und HerzklappenerkrankungenIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 6, S. E36
-
Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headacheIn: The Journal of Headache and Pain, Jg. 17, 2016, S. 43DOI (Open Access)
-
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic strokeIn: International Journal of Stroke, Jg. 11, 2016, Nr. 3, S. 302 – 312
-
Die SOCRATES Studie : Ticagrelor vs. Aspirin zur frühen Schlaganfall-PräventionIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 6, S. E40
-
Does neurological symptom duration affect the incidence of atrial fibrillation in patients monitored continously following cryptogenic stroke?In: International Journal of Stroke, Jg. 11, 2016, Nr. Suppl. 3, S. 226 – 226
-
Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment studyIn: American Heart Journal, Jg. 178, 2016, S. 145 – 150
-
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke : time-course analysis of randomised trialsIn: Lancet, Jg. 388, 2016, Nr. 10042, S. 365 – 375DOI (Open Access)
-
Embolic Stroke, Atrial Fibrillation, and Microbleeds : Is There a Role for Anticoagulation?In: Stroke, Jg. 47, 2016, Nr. 3, S. 904 – 907
-
Endovascular thrombectomy after large-vessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trialsIn: Lancet, Jg. 387, 2016, Nr. 10029, S. 1723 – 1731
-
Erfolge der mechanischen Thrombektomie beim akuten ischämischen Insult machen eine Aktualisierung der DGN-Leitlinien notwendigIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 2, S. 81
-
European headache federation consensus on technical investigation for primary headache disordersIn: The Journal of Headache and Pain, Jg. 17, 2016, Nr. 1, S. 5DOI (Open Access)
-
Fragen aus der Facharztprüfung NeurologieIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 84, 2016, Nr. 4, S. 230 – 232
-
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE) : a case-control studyIn: Lancet, Jg. 388, 2016, Nr. 10046, S. 761 – 775
-
Größe und funktioneller Outcome intracerebraler Blutungen unter oraler AntikoagulationIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 6, S. E43
-
Headache research in 2015 : progress in migraine treatmentIn: The Lancet Neurology, Jg. 15, 2016, Nr. 1, S. 4 – 5
-
Impact of heart rate on admission on mortality and morbidity in acute ischaemic stroke patients - results from VISTAIn: European Journal of Neurology, Jg. 23, 2016, Nr. 12, S. 1750 – 1756
-
Improving the detection of chronic migraine : Development and validation of Identify Chronic Migraine (ID-CM)In: Cephalalgia, Jg. 36, 2016, Nr. 3, S. 203 – 215DOI, Online Volltext (Open Access)
-
Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIMEIn: Annals of Neurology, Jg. 79, 2016, Nr. 1, S. 76 – 89
-
Klinik : Intraarterielle Behandlung von Patienten mit akutem ischämischen Schlaganfall unter oraler AntikoagulantionIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 5, S. E29
-
Klinik : Risiko einer Vorbehandlung mit Thrombozytenfunktionshemmern bei lysierten PatientenIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 5, S. E27
-
Kongressbericht – International Stroke Conference 2016In: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 84, 2016, Nr. 7, S. 398 – 400
-
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillationIn: EP Europace, Jg. 18, 2016, Nr. 7, S. 973 – 978DOI (Open Access)
-
Medication-overuse headache : risk factors, pathophysiology and managementIn: Nature Reviews Neurology, Jg. 12, 2016, Nr. 10, S. 575 – 583
-
Neue Rubrik der Aktuellen Neurologie : Versorgungsstrukturen in der NeurologieIn: Aktuelle Neurologie, Jg. 43, 2016, Nr. 6, S. 351
-
Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled studyIn: Cephalalgia, Jg. 36, 2016, Nr. 6, S. 534 – 546DOI (Open Access)
-
Non-vitamin K oral anticoagulants in stroke patients : Practical issuesIn: Journal of Stroke, Jg. 18, 2016, Nr. 2, S. 138 – 145DOI (Open Access)
-
Online Tool to Improve Stratification of Adverse Events in Stroke Clinical TrialsIn: Stroke, Jg. 47, 2016, Nr. 3, S. 882 – 885
-
PFO : "Please Figure Out," or Now "Potentially Figured Out?"In: Journal of the American College of Cardiology (JACC), Jg. 67, 2016, Nr. 8, S. 918 – 920DOI (Open Access)
-
Percutaneous left atrial appendage occlusion : the Munich consensus document on definitions, endpoints and data collection requirements for clinical studiesIn: EuroIntervention, Jg. 12, 2016, Nr. 1, S. 103 – 111DOI, Online Volltext (Open Access)
-
Predictors for atrial fibrillation detection after cryptogenic stroke : Results from CRYSTAL AFIn: Neurology, Jg. 86, 2016, Nr. 3, S. 261 – 269DOI, Online Volltext (Open Access)
-
RE-SPECT ESUS* Trial : Rationale and DesignIn: Cerebrovascular Diseases, Jg. 42, 2016, Nr. Suppl. 1, S. 117
-
Real-World Use of Prophylactic Antibiotics in Insertable Cardiac Monitor ProceduresIn: Pacing and Clinical Electrophysiology: PACE, Jg. 39, 2016, Nr. 8, S. 837 – 842DOI (Open Access)
-
S3-Leitlinie - Prophylaxe der venösen Thromboembolie (VTE) : Zweite, komplett überarbeitete Auflage vom 15.10.2015In: VASA: European Journal of Vascular Medicine, Jg. 45, 2016, Nr. Suppl. 92, S. 9 – 87DOI (Open Access)
-
Safety and Efficacy of Solitaire Stent Thrombectomy : Individual Patient Data Meta-Analysis of Randomized TrialsIn: Stroke, Jg. 47, 2016, Nr. 3, S. 798 – 806DOI (Open Access)
-
Schlaganfälle : 10 beeinflussbare Faktoren machen 90 % des Risikos aus – weltweitIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 141, 2016, Nr. 22, S. 1606
-
Sex differences in antithrombotic therapy : Observations from the Gloria-AF Registry ProgramIn: Journal of the American College of Cardiology (JACC), Jg. 67, 2016, Nr. Suppl. 13, S. 794
-
Statins and risk of poststroke hemorrhagic complicationsIn: Neurology, Jg. 86, 2016, Nr. 17, S. 1590 – 1596DOI, Online Volltext (Open Access)
-
Stroke Severity and Comorbidity Index for Prediction of Mortality after Ischemic Stroke from the Virtual International Stroke Trials Archive-Acute CollaborationIn: Journal of Stroke and Cerebrovascular Diseases, Jg. 25, 2016, Nr. 4, S. 835 – 842DOI (Open Access)
-
Therapieoptionen bei asymptomatischer Karotisstenose : Asymptomatic Carotid Trial (ACT I) und Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)In: Der Internist, Jg. 57, 2016, Nr. 10, S. 1037 – 1040
-
Therapieoptionen bei asymptomatischer Karotisstenose : Asymptomatic Carotid Trial (ACT I) und Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)In: Der Internist, Jg. 57, 2016, Nr. 10, S. 1037 – 1040
-
Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients : Three-year results from the cryptogenic stroke and underlying atrial fibrillation trialIn: Circulation: Arrhythmia and Electrophysiology, Jg. 9, 2016, Nr. 1, S. e003333DOI (Open Access)
-
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: Statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaborationIn: International Journal of Stroke, Jg. 10, 2015, Nr. Issue Supplement A100, S. 136 – 144
-
A comparison of atrial fibrillation monitoring strategies after cryptogenic stroke (from the cryptogenic stroke and underlying AF trial)In: The American Journal of Cardiology, Jg. 116, 2015, Nr. 6, S. 890 – 893DOI (Open Access)
-
Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation : the GLORIA-AF Registry, phase IIIn: The American Journal of Medicine, Jg. 128, 2015, Nr. 12, S. 1306 – 1313e1
-
Assessing Clinically Meaningful Treatment Effects in Controlled Trials : Chronic Migraine as an ExampleIn: The Journal of Pain, Jg. 16, 2015, Nr. 2, S. 164 – 175
-
Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy : Analysis from VISTAIn: European Journal of Neurology, Jg. 22, 2015, Nr. 7, S. 1048 – 1055
-
Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis : analysis from VISTAIn: European Journal of Neurology, Jg. 22, 2015, Nr. 1, S. 163 – 169
-
Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN) : study protocol for a randomized controlled trialIn: Trials, Jg. 16, 2015, Nr. 1, S. 550DOI (Open Access)
-
Brain meets heart : neues zur Detektion von Vorhofflimmern, Kryptogener SchlaganfallIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 140, 2015, Nr. S 01, S. 3 – 4
-
Calcitonin Gene-Related Peptide und MigräneIn: Arzneimitteltherapie (AMT), Jg. 33, 2015, Nr. 6, S. 181 – 184
-
Changes in renal function in patients with atrial fibrillation: An analysis from the RE-LY trialIn: Journal of the American College of Cardiology (JACC), Jg. 65, 2015, Nr. 23, S. 2481 – 2493DOI (Open Access)
-
Design of Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (Re-Spect Esus)In: International Journal of Stroke, Jg. 10, 2015, Nr. 8, S. 1309 – 1312
-
Endovascular stent thrombectomy : The new standard of care for large vessel ischaemic strokeIn: The Lancet Neurology, Jg. 14, 2015, Nr. 8, S. 846 – 854
-
Endovaskuläre Therapie bei akutem ischämischem Insult : Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN)In: Der Internist, Jg. 56, 2015, Nr. 7, S. 847 – 850
-
Fampridin zur Verbesserung der Gangfunktion bei Patienten mit Multipler Sklerose – KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 9, S. 546
-
Frauenspezifische Therapie der Migräne : Typische BehandlungskonstellationenIn: Arzneimitteltherapie (AMT), Jg. 33, 2015, Nr. 9, S. 288 – 294
-
Frühtherapie der Multiplen Sklerose : KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 2, S. 102
-
Hoch dosiertes Vitamin E zur Behandlung des Morbus Alzheimer : sinnvoll oder sinnlos? ; KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 5, S. 276
-
IQWiG Arbeitspapier GA15-02: "Stents zur Behandlung intrakranieller Stenosen: VISSIT Studie und Akutbehandlung in Deutschland" : Kommentar des Berufsverbandes der Neuroradiologen (BDNR), der Deutschen Gesellschaft für Neuroradiologie (DGNR), der Deutschen Gesellschaft für Neurologie (DGN) und der Deutschen Schlaganfall-Gesellschaft (DSG).In: Clinical Neuroradiology, Jg. 25, 2015, Nr. 4, S. 445 – 449
-
IQWiG-Arbeitspapier GA15-02 : Stents zur Behandlung intrakranieller Stenosen: VISSIT-Studie und Akutbehandlung in DeutschlandIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 8, S. 441 – 444
-
Idiopathisches Parkinson-Syndrom : Wertigkeit von systemischen alpha-Synuklein-Ablagerungen – KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 8, S. 487
-
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10 : a randomized, placebo-controlled, double-blind, multicenter trialIn: The Journal of Headache and Pain, Jg. 16, 2015, S. 32DOI (Open Access)
-
Individual patient data meta-analysis of antiplatelet regimens after noncardioembolic stroke or TIA : Rationale and designIn: International Journal of Stroke, Jg. 10, 2015, Nr. A100, S. 145 – 150
-
Infarct Topography and Detection of Atrial Fibrillation in Cryptogenic Stroke : Results from CRYSTAL AFIn: Cerebrovascular Diseases, Jg. 40, 2015, Nr. 1-2, S. 91 – 96
-
Integrated care for chronic migraine patients : epidemiology, burden, diagnosis and treatment optionsIn: Clinical Medicine, Jg. 15, 2015, Nr. 4, S. 344 – 350
-
Kombinationstherapie zweier AntikoagulanzienIn: Chirurgische Praxis, Jg. 80, 2015, Nr. 2, S. 264
-
Kombinationstherapie zweier AntikoagulanzienIn: Internistische Praxis, Jg. 55, 2015, Nr. 2, S. 284
-
Kryptogener Schlaganfall - antikoagulieren oder nicht antikoagulieren : das ist hier die Frage - KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 3, S. 171
-
Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care : the dizziness and vertigo registry (DiVeR) studyIn: Journal of Neurology, Jg. 262, 2015, Nr. 9, S. 2083 – 2091
-
MR-Bildgebung beim akuten ischämischen Insult : KommentarIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 3, S. 166
-
Mechanische Thrombektomie bei akutem ischämischem Schlaganfall : Wo stehen wir nach den jüngsten Studienergebnissen?In: Der Nervenarzt, Jg. 86, 2015, Nr. 6, S. 719 – 724
-
Neue medikamentöse und neuromodulatorische Therapieansätze zur Behandlung der MigräneIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 6, S. 315 – 322
-
Neues zu Kopfschmerzen 2015 – ein UpdateIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 5, S. 247 – 255
-
New therapeutic approaches for the prevention and treatment of migraineIn: The Lancet Neurology, Jg. 14, 2015, Nr. 10, S. 1010 – 1022
-
Non-ruptered AVMs : to treat or not to treat - commentIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 10, S. 616
-
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle : PREEMPTIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 86, 2015, Nr. 9, S. 996 – 1001DOI (Open Access)
-
Persistent postural-perceptual dizziness : A matter of higher, central dysfunction?In: PLoS ONE, Jg. 10, 2015, Nr. 11, S. e0142468DOI (Open Access)
-
Personalisierte Neuroonkologie – der heilige Gral ist noch weit entfernt : personalized neuro-oncology – the Holy Grail is far awayIn: Aktuelle Neurologie, Jg. 42, 2015, Nr. 1, S. 40
-
Pharmacotherapy options for cluster headacheIn: Expert Opinion on Pharmacotherapy, Jg. 16, 2015, Nr. 8, S. 1177 – 1184
-
Practical implications of the migraine cardio- and cerebrovascular association : Unmet needs of patientsIn: Cephalalgia, Jg. 35, 2015, Nr. 2, S. 140 – 145
-
Relationships between imaging assessments and outcomes in solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic strokeIn: Stroke, Jg. 46, 2015, Nr. 10, S. 2786 – 2794DOI (Open Access)
-
Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial : Protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic strokeIn: International Journal of Stroke, Jg. 10, 2015, Nr. 3, S. 439 – 448DOI, Online Volltext (Open Access)
-
State of Acute Endovascular Therapy : Report from the 12th Thrombolysis, Thrombectomy, and Acute Stroke Therapy ConferenceIn: Stroke, Jg. 46, 2015, Nr. 6, S. 1727 – 1734
-
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in strokeIn: The New England Journal of Medicine, Jg. 372, 2015, Nr. 24, S. 2285 – 2295DOI (Open Access)
-
Stroke prevention with rivaroxaban in higher-risk populations with atrial fibrillationIn: International Journal of Clinical Practice, Jg. 69, 2015, Nr. 7, S. 743 – 756DOI (Open Access)
-
Stroke: Stroke prevention : time to say goodbye to the ABCD2 score?In: Nature Reviews Neurology, Jg. 11, 2015, Nr. 10, S. 552 – 553
-
Surgical treatment for migraine : Time to fight against the knifeIn: Cephalalgia, Jg. 35, 2015, Nr. 6, S. 465 – 468
-
Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular RiskNovelty and SignificanceIn: Hypertension, Jg. 65, 2015, Nr. 3, S. 651 – 661
-
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular riskIn: Hypertension, Jg. 65, 2015, Nr. 3, S. 651 – 661
-
The European Stroke Organisation Guidelines : A standard operating procedureIn: International Journal of Stroke, Jg. 10, 2015, Nr. A100, S. 128 – 135
-
The association between stress and headache : A longitudinal population-based studyIn: Cephalalgia, Jg. 35, 2015, Nr. 10, S. 853 – 863
-
The authors reply [Stent-Retriever Thrombectomy for Stroke]In: The New England Journal of Medicine, Jg. 373, 2015, Nr. 11, S. 1077
-
Updated European Heart Rhythm Association Practical Guide on the use of non-Vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillationIn: EP Europace, Jg. 17, 2015, Nr. 10, S. 1467 – 1507
-
Use of aspirin combinations with caffeine and increasing headache frequency: A prospective population-based studyIn: Pain, Jg. 156, 2015, Nr. 9, S. 1747 – 1754
-
Vorhofflimmern : Wie effektiv und sicher sind die direkten oralen Antikoagulanzien zur Prävention von Schlaganfällen?In: Deutsche Medizinische Wochenschrift - DMW, Jg. 140, 2015, Nr. 10, S. 750 – 755
-
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation : Proceedings, Washington, DC, December 3-4, 2012In: American Heart Journal, Jg. 168, 2014, Nr. 3, S. 239 – 247.e1
-
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgiaIn: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl.1, S. E21DOI (Open Access)
-
Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhageIn: Expert Review of Neurotherapeutics, Jg. 14, 2014, Nr. 9, S. 1019 – 1028
-
Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headacheIn: The Journal of Headache and Pain, Jg. 15, 2014, S. 46DOI (Open Access)
-
CGRP as a new target in prevention and treatment of migraineIn: The Lancet Neurology, Jg. 13, 2014, Nr. 11, S. 1065 – 1067
-
Central vestibular system modulation in vestibular migraineIn: Cephalalgia, Jg. 34, 2014, Nr. 13, S. 1053 – 1061
-
Central vestibular system modulation in vestibular migraine - a VBM study.In: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl.1, S. E42DOI (Open Access)
-
Concomitant occurrence of different trigeminal autonomic cephalalgias : A case series and review of the literatureIn: Cephalalgia, Jg. 34, 2014, Nr. 3, S. 231 – 235
-
Cortical plasticity in episodic and chronic cluster headacheIn: NeuroImage: Clinical, Jg. 6, 2014, S. 415 – 423DOI (Open Access)
-
Cryptogenic stroke and atrial fibrillationIn: The New England Journal of Medicine, Jg. 371, 2014, Nr. 13, S. 1259 – 1262
-
Cryptogenic stroke and underlying atrial fibrillationIn: The New England Journal of Medicine, Jg. 370, 2014, Nr. 26, S. 2478 – 2486
-
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation : A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillationIn: American Heart Journal, Jg. 167, 2014, Nr. 3, S. 329 – 334
-
Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke : a post hoc analysisIn: European Journal of Neurology, Jg. 21, 2014, Nr. 10, S. 1311 – 1317DOI (Open Access)
-
Dr. Sanna and colleagues reply [Atrial Fibrillation in Patients with Cryptogenic Stroke]In: The New England Journal of Medicine, Jg. 371, 2014, Nr. 13, S. 1261
-
ECG monitoring with implanted monitors increased AF detection more than usual follow-up after cryptogenic strokeIn: Annals of Internal Medicine, Jg. 161, 2014, Nr. 10, S. JC3
-
Efficacy of NeuroFlo Device in Treatment of Patients with Atrial FibrillationIn: Journal of Stroke and Cerebrovascular Diseases, Jg. 23, 2014, Nr. 6, S. 1457 – 1461
-
Embolic strokes of undetermined source : support for a new clinical construct–Authors' replyIn: The Lancet Neurology, Jg. 13, 2014, Nr. 10, S. 967
-
Embolic strokes of undetermined source : the case for a new clinical constructIn: The Lancet Neurology, Jg. 13, 2014, Nr. 4, S. 429 – 438
-
Erratum: Praktische Anwendung der neuen Antikoagulanzien bei Patienten mit TIA und Schlaganfall und Vorhofflimmern bei absoluter ArrhythmieIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 3, S. e42
-
IQWiG und intrakranielle Stents für die Sekundärprävention des SchlaganfallsIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 9, S. 501
-
Impact of benzodiazepines on functional outcome and occurrence of pneumonia in stroke: Evidence from VISTAIn: International Journal of Stroke, Jg. 9, 2014, Nr. 7, S. 890 – 894
-
Influences of smoking and caffeine consumption on trigeminal pain processingIn: The Journal of Headache and Pain, Jg. 15, 2014, S. 39DOI (Open Access)
-
Interdependence of stroke outcome scales : Reliable estimates from the Virtual International Stroke Trials Archive (VISTA)In: International Journal of Stroke, Jg. 9, 2014, Nr. 3, S. 328 – 332
-
Interventionelle Therapie von symptomatischen intrakraniellen Gefäßstenosen : KommentarIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 1, S. 45
-
Intracluster correlation coefficients and reliability of randomized multicenter stroke trials within VISTAIn: International Journal of Stroke, Jg. 9, 2014, Nr. 5, S. 602 – 606
-
Is there a period of liability with initiation of warfarin in patients with atrial fibrillation?In: European Heart Journal, Jg. 35, 2014, Nr. 28, S. 1834 – 1835
-
Jährlich 19 000 Tote durch Behandlungsfehler im Krankenhaus? : 19 000 Annual Deaths in German Hospitals due to Treatment Errors?In: Aktuelle Neurologie, Jg. 41, 2014, Nr. 3, S. 139
-
Jährlich 19 000 Tote durch Behandlungsfehler im Krankenhaus?In: Aktuelle Neurologie, Jg. 41, 2014, Nr. 3, S. 139
-
Kaffee erhöht das Schlaganfallrisiko nichtIn: MMW - Fortschritte der Medizin, Jg. 156, 2014, Nr. 9, S. 31
-
Kryptogener ischämischer Schlaganfall : Zeit für einen Paradigmenwechsel in Diagnose und Therapie?In: Aktuelle Neurologie, Jg. 41, 2014, Nr. 1, S. 35 – 39
-
Modulation of central pain processing by anodal direct current stimulation – a fMRI study.In: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl.1, S. E20DOI (Open Access)
-
Neues in der Primär- und Sekundärprävention des SchlaganfallsIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 2, S. 83 – 89
-
Non-invasive vagus nerve stimulation using gammacore® for prevention and acute treatment of chronic cluster headache : report from the randomized phase of the preva studyIn: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl.1, Abstracts from the 4th European Headache and Migraine Trust International Congress: EHMTIC 2014, S. I7DOI (Open Access)
-
Non-invasive vagus nerve stimulation with gammacore® for prevention and acute treatment of chronic cluster headache : report from the extension phase of the preva studyIn: The Journal of Headache and Pain, Jg. 15, 2014, S. I8DOI (Open Access)
-
OnabotulinumtoxinA for chronic migraine : Efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical programIn: Acta Neurologica Scandinavica, Jg. 129, 2014, Nr. 1, S. 61 – 70DOI (Open Access)
-
Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgiaIn: The Journal of Headache and Pain, Jg. 15, 2014, S. 78DOI (Open Access)
-
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraineIn: European Journal of Neurology, Jg. 21, 2014, Nr. 6, S. 851 – 859DOI (Open Access)
-
Praktische Anwendung der neuen Antikoagulanzien bei Patienten mit TIA und Schlaganfall und Vorhofflimmern bei absoluter ArrhythmieIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 3, S. 146 – 155
-
Probability estimation with machine learning methods for dichotomous and multicategory outcome : ApplicationsIn: Biometrical Journal, Jg. 56, 2014, Nr. 4, S. 564 – 583
-
Quality of life in subjects treated by non-invasive vagus nerve stimulation using gammacore® for the prevention and acute treatment of chronic cluster headacheIn: The Journal of Headache and Pain, Jg. 15, 2014, S. I6DOI (Open Access)
-
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacksIn: Cephalalgia, Jg. 34, 2014, Nr. 2, S. 103 – 113DOI, Online Volltext (Open Access)
-
Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS)In: International Journal of Stroke, Jg. 9, 2014, Nr. Suppl. 3, S. 216
-
Schlaganfallprävention bei symptomatischer Karotisstenose: Operation oder Stenting? – KommentarIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 6, S. 364
-
Study protocol of BoTN : a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of botulinum toxin injections in the treatment of trigeminal neuralgiaIn: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl. 1, S. C9DOI (Open Access)
-
Subarachnoidalblutung einfach erkanntIn: MMW - Fortschritte der Medizin, Jg. 156, 2014, Nr. 2, S. 38
-
The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest TreatmentIn: Journal of Stroke, Jg. 16, 2014, Nr. 2, S. 57 – 58DOI (Open Access)
-
The association between stress and headache : a longitudinal population-based studyIn: The Journal of Headache and Pain, Jg. 15, 2014, Nr. Suppl. 1, S. F23DOI (Open Access)
-
The atrial fibrillation epidemic is approaching the physician's door : will mobile technology improve detection?In: BMC Medicine, Jg. 12, 2014, Nr. 1, S. 180DOI (Open Access)
-
Therapie der CIDP : was ist die 1. Wahl? – KommentarIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 3, S. 178
-
Therapie der chronischen Migräne : Treatment of chronic migraineIn: Arzneimitteltherapie (AMT), Jg. 32, 2014, Nr. 6, S. 155 – 158
-
Thrombektomie beim akuten ischämischen Insult ist und wird eine Routinemethode - ProIn: Aktuelle Neurologie, Jg. 41, 2014, Nr. 8, S. 469 – 470
-
Thrombolyse beim akuten ischämischen zerebralen InsultIn: Arzneimitteltherapie (AMT), Jg. 32, 2014, Nr. 5, S. 125 – 132
-
To monitor or to not monitor for paroxysmal atrial fibrillation after transient ischemic attack or stroke : this is the questionIn: Stroke, Jg. 45, 2014, Nr. 2, S. 355 – 356
-
Treating medication overuse headache : More than improving headacheIn: Cephalalgia, Jg. 34, 2014, Nr. 6, S. 405 – 406
-
Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry ProgramIn: Pharmacoepidemiology and Drug Safety, Jg. 23, 2014, Nr. Suppl.1, S. 13
-
Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache : meta-analysis of four randomized, double-blind, placebo-controlled, crossover studiesIn: The Journal of Headache and Pain, Jg. 15, 2014, S. 76DOI (Open Access)
-
Use of dihydroergotamine (DHE) should be restricted to no more than twice a weekIn: Headache: The Journal of Head and Face Pain, Jg. 54, 2014, Nr. 9, S. 1523 – 1525
-
Was sollen Leitlinien, was können Leitlinien?In: Der Schmerz, Jg. 28, 2014, Nr. 3, S. 228 – 229
-
gammaCore (R) Use for Prevention and Acute Treatment of Chronic Cluster Headache : Findings from the Randomized Phase of the PREVA StudyIn: Annals of Neurology, Jg. 76, 2014, Nr. Suppl. 18, S. 104
-
Acupuncture prophylaxis of migraine no better than sham acupuncture for decreasing frequency of headachesIn: Evidence-Based Medicine, Jg. 18, 2013, Nr. 1, S. 33 – 34
-
Akutdiagnostik und Akuttherapie des ischämischen InsultesIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 138, 2013, Nr. 9, S. 423 – 436
-
Apixaban zur Prävention von Schlaganfällen und systemischen Embolien bei Patienten mit VorhofflimmernIn: Arzneimitteltherapie (AMT), Jg. 31, 2013, Nr. 5, S. 123 – 129
-
Chronic migraine and chronic tension-type headache are associated with concomitant low back pain : Results of the German Headache Consortium studyIn: Pain, Jg. 154, 2013, Nr. 3, S. 484 – 492
-
Chronic pain syndromes after ischemic stroke : PRoFESS trialIn: Stroke, Jg. 44, 2013, Nr. 5, S. 1238 – 1243
-
Clopidogrel added to Aspirin adds no benefit but bleeding risk in patients with recent lacunar strokeIn: Stroke, Jg. 44, 2013, Nr. 3, S. 861 – 863
-
Coxibe oder NSAR : Was wird besser vertragen?In: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 19, S. 35
-
Der Wissenserwerb junger Mediziner ändert sichIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 9, S. 477
-
Die Coronary Artery Bypass graft surgery in patients with Asymptomatic Carotid Stenosis (CABACS) RCT Studie : Rationale, Stand und PerspektivenIn: Gefäßchirurgie, Jg. 18, 2013, Nr. 7, S. 638 – 643
-
Die neue S3-Leitlinie „Schlaganfallprävention“ der Deutschen Gesellschaft für Neurologie und der Deutschen Schlaganfall-GesellschaftIn: Psychopharmakotherapie, Jg. 20, 2013, Nr. 2, S. 58 – 65
-
Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events : Results from the PRoFESS studyIn: Cerebrovascular Diseases, Jg. 35, 2013, Nr. 6, S. 538 – 543
-
Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?In: International Journal of Stroke, Jg. 8, 2013, Nr. 8, S. 652 – 656
-
Endovascular stroke trials : Why we must enroll all eligible patientsIn: Stroke, Jg. 44, 2013, Nr. 12, S. 3591 – 3595
-
Epidemiological profiles of patients with chronic migraine and chronic tension-type headacheIn: The Journal of Headache and Pain, Jg. 14, 2013, S. 40DOI (Open Access)
-
Episodische Migräne : Was schützt vor der nächsten Attacke?In: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 14, S. 29
-
Failures, mistakes and shortcomings of my stroke trialsIn: Cerebrovascular Diseases, Jg. 36, 2013, Nr. 4, S. 250 – 256
-
Gray matter volume reduction reflects chronic pain in trigeminal neuralgiaIn: NeuroImage, Jg. 74, 2013, S. 352 – 358
-
Headache : Insight, understanding, treatment and patient managementIn: International Journal of Clinical Practice, Jg. 67, 2013, Nr. Suppl. 178, Special Issue: 50 Years of Ibuprofen, S. 33 – 36
-
Headache associated with Medication Overuse Cortisone during Medication Overuse Headache - Yes or no?In: Aktuelle Neurologie, Jg. 40, 2013, Nr. 8, S. E22 – E23
-
Intima-Media-Dicke der A. carotis als kardiovaskulärer Prädiktor : Progression Intima-Media Thickness (PROG-IMT)In: Der Internist, Jg. 54, 2013, Nr. 4, S. 505 – 506
-
Komorbiditäten der Migräne : praktische BehandlungskonsequenzenIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 4, S. 213 – 223
-
Kortikosteroide bei „Ischias“ überschätztIn: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 17, S. 33
-
Kritischer Kommentar zu den Empfeh lungen zum Einsatz der neuen Anti koagulanzien Dabigatran und Rivaroxa ban" der Arzneimittel-kommission der deutschen ÄrzteschaftIn: Perfusion: Kreislauf- und Stoffwechselerkrankungen in Klinik und Praxis, Jg. 26, 2013, Nr. 1, S. 8 – 10
-
Kritischer Kommentar zu den „Empfehlungen zum Einsatz der neuen Antikoagulanzien Dabigatran (Pradaxa®) und Rivaroxaban (Xarelto®)“ der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) : Gemeinsame Stellungnahme der Deutschen Gesellschaft für Neurologie (DGN) und der Deutschen Schlaganfall-Gesellschaft (DSG)In: Aktuelle Neurologie, Jg. 40, 2013, Nr. 2, S. 101 – 103
-
Lakunärer Schlaganfall : Blutdruck aggressiv senken?In: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 20, S. 34
-
Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulationIn: Stroke, Jg. 44, 2013, Nr. 11, S. 3223 – 3225
-
Migraine prophylaxis : Which drugs work and which ones don'tIn: Journal of General Internal Medicine (JGIM), Jg. 28, 2013, Nr. 9, S. 1125 – 1126
-
Migräne führt nicht zu kognitiven StörungenIn: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 1, S. 36
-
Miscellaneous New US-American Stroke DefinitionIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E58
-
Neues in der Primär- und Sekundärprävention des SchlaganfallsIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 2, S. 70 – 78
-
Neues zu Kopfschmerzen 2013 : ein UpdateIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 7, S. 393 – 399
-
No evidence of jugular venous valve insufficiency in patients with migraine : a controlled studyIn: The Journal of Headache and Pain, Jg. 14, 2013, S. 52DOI (Open Access)
-
Novel oral anticoagulants in secondary prevention of strokeIn: Best Practice & Research Clinical Haematology, Jg. 26, 2013, Nr. 2, S. 131 – 139
-
Occipital nerve stimulation for intractable chronic cluster headache or migraine : a critical analysis of direct treatment costs and complicationsIn: Cephalalgia, Jg. 33, 2013, Nr. 16, S. 1283 – 1291
-
OnabotulinumtoxinA for treatment of chronic migraine : PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baselineIn: Journal of the Neurological Sciences, Jg. 331, 2013, Nr. 1-2, S. 48 – 56
-
Prednisone for the treatment of withdrawal headache in patients with medication overuse headache : a randomized, double-blind, placebo-controlled studyIn: Cephalalgia, Jg. 33, 2013, Nr. 3, S. 202 – 207
-
Prevalence of cardiac right left shunts in migraine : A population-based case-control studyIn: Neurological Sciences, Jg. 34, 2013, Nr. 2, S. 205 – 208
-
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation."In: Thrombosis and Haemostasis, Jg. 110, 2013, Nr. 3, S. 493 – 495
-
Progressive multifocal leukoencephalopathy of the brainstem in an immunocompetent patient—JC and BK polyoma-virus coinfection? : A case report and review of the literatureIn: Clinical Neurology and Neurosurgery, Jg. 115, 2013, Nr. 11, S. 2390 – 2392
-
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxabanIn: Clinical Research in Cardiology, Jg. 102, 2013, Nr. 6, S. 399 – 412
-
Results of membrane-activated chelator stroke intervention randomized trial of DP-b99 in acute ischemic strokeIn: Stroke, Jg. 44, 2013, Nr. 3, S. 580 – 584
-
Secondary Prevention Clopidogrel and Aspirin vs. Aspirin for Early ProphylaxisIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E55
-
Secondary Prevention Early Start of oral AnticoagulationIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E52 – E52
-
Secondary Prevention PFO-Closure after cryptogenic StrokeIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E50
-
Secondary Prevention Stroke Prevention through Closure of an open Foramen ovaleIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E53
-
Stroke : A new CHANCE for combination antiplatelet therapy?In: Nature Reviews Neurology, Jg. 9, 2013, Nr. 10, S. 549 – 550
-
Stroke patients with suspected atrial fibrillation should be started on anticoagulation pending the results of long-term cardiac monitoringIn: Stroke, Jg. 44, 2013, Nr. 1, S. 298 – 299
-
Study protocol of Prednisone in episodic Cluster Headache (PredCH) : a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamilIn: BMC Neurology, Jg. 13, 2013, S. 99DOI (Open Access)
-
Stärken und Grenzen der neuen Antikoagulanzienhofflimmern : Schlaganfallprävention bei VorhofflimmernIn: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 8, S. 55 – 58
-
The International Classification of Headache Disorders, 3rd edition (beta version)In: Cephalalgia, Jg. 33, 2013, Nr. 9, S. 629 – 808DOI (Open Access)
-
Therapie des Kopfschmerzes bei Medikamentenübergebrauch : Evidenzbasierte Empfehlungen der Deutschen Migräneund Kopfschmerzgesellschaft (DMKG), der Deutschen Gesellschaft für Neurologie (DGN), der Österreichischen Kopfschmerzgesellschaft (ÖKSG) und der Schweizerischen Kopfwehgesellschaft (SKG)In: Nervenheilkunde, Jg. 32, 2013, Nr. 3, S. 135 – 144
-
Topiramate inMigraine prophylaxisIn: European Neurological Journal: ENJ, Jg. 4, 2013, Nr. 2
-
Treatment guideline for medication overuse headacheIn: Nervenheilkunde, Jg. 32, 2013, Nr. 3, S. 135 – 144
-
Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatmentIn: The Lancet Neurology, Jg. 12, 2013, Nr. 7, S. 677 – 688
-
Unspezifischer Rückenschmerz : Akupunktur sticht übliche TherapieIn: MMW - Fortschritte der Medizin, Jg. 155, 2013, Nr. 2, S. 33
-
Vascular Dementia Atrial Fibrillation and cognitive DegenerationIn: Aktuelle Neurologie, Jg. 40, 2013, Nr. 10, S. E56
-
Vorbeugung und Behandlung des Schlaganfalls : Wissenschaftliche Entwicklungen und Fortschritte der letzten 30 JahreIn: Unikate: Berichte aus Forschung und Lehre, 2013, Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 84 – 91DOI, Online Volltext (Open Access)
-
Worauf kommt es beim Lesen von Therapiestudien an?In: Aktuelle Neurologie, Jg. 40, 2013, Nr. 1, S. 22 – 28
-
Aerobic endurance training versus relaxation training in patients with migraine (ARMIG) : study protocol for a randomized controlled trialIn: Trials, Jg. 13, 2012, Nr. 1, S. 46DOI, Online Volltext (Open Access)
-
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : a subgroup analysis of the ARISTOTLE trialIn: The Lancet Neurology, Jg. 11, 2012, Nr. 6, S. 503 – 511
-
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : A predefined subgroup analysis from AVERROES, a randomised trialIn: The Lancet Neurology, Jg. 11, 2012, Nr. 3, S. 225 – 231
-
Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulationIn: The Journal of Headache and Pain, Jg. 13, 2012, Nr. 1, S. 83 – 89DOI (Open Access)
-
Botulinumtoxin zur Prophylaxe von Migräne und SpannungskopfschmerzIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 13, S. 40
-
Chronic Daily Headache Is Associated with Somatoform Vertigo and DizzinessIn: Neurology, Jg. 78, 2012, Nr. Suppl. 1, S. 16003
-
Chronic Migraine (CM) and Chronic Tension-Type Headache Are Associated with Concomitant Frequent Back PainIn: Neurology, Jg. 78, 2012, Nr. Suppl. 1, S. P04260
-
Chronic migraine - Classification, characteristics and treatmentIn: Nature Reviews Neurology, Jg. 8, 2012, Nr. 3, S. 162 – 171
-
Chronische Kreuzschmerzen : Kortison hilft nichtIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 3, S. 44
-
Cluster headache shows no association with rapid eye movement sleepIn: Cephalalgia, Jg. 32, 2012, Nr. 4, S. 289 – 296
-
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysisIn: International Angiology, Jg. 31, 2012, Nr. 4, S. 330 – 339
-
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options : a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conferenceIn: EP Europace, Jg. 14, 2012, Nr. 1, S. 8 – 27
-
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation : Resolving uncertainties in routine practiceIn: Thrombosis and Haemostasis, Jg. 107, 2012, Nr. 5, S. 838 – 847
-
Dabigatran for stroke prevention in atrial fibrillationIn: Hämostaseologie, Jg. 32, 2012, Nr. 3, S. 216 – 220
-
Detoxification for medication overuse headache is not necessaryIn: Cephalalgia, Jg. 32, 2012, Nr. 5, S. 423 – 427
-
Development, Expansion, and Use of a Stroke Clinical Trials Resource for Novel Exploratory AnalysesIn: International Journal of Stroke, Jg. 7, 2012, Nr. 2, S. 133 – 138
-
Differences in clinical characteristics and frequency of accompanying migraine features in episodic and chronic cluster headacheIn: Cephalalgia, Jg. 32, 2012, Nr. 7, S. 571 – 577
-
Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack : Systematic Review and Meta-Analysis of Randomized Controlled TrialsIn: Stroke, Jg. 43, 2012, Nr. 4, S. 1058 – 1066DOI (Open Access)
-
Effects of age on outcome in the SENTIS trial : Better outcomes in elderly patientsIn: Cerebrovascular Diseases, Jg. 34, 2012, Nr. 4, S. 263 – 271
-
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging studyIn: The Lancet Neurology, Jg. 11, 2012, Nr. 5, S. 405 – 413
-
Fibromyalgieschmerz wegtrainierenIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 12, S. 39
-
Gray-Matter Decrease in Chronic Somatoform Vertigo - A VBM StudyIn: Neurology, Jg. 78, 2012, Nr. Suppl. 1, S. P02253
-
Guidelines for controlled trials of drugs in migraine: Third edition : A guide for investigatorsIn: Cephalalgia, Jg. 32, 2012, Nr. 1, S. 6 – 38
-
Habituation of the nociceptive blink reflex in episodic and chronic cluster headacheIn: Cephalalgia, Jg. 32, 2012, Nr. 13, S. 998 – 1004
-
Hypnic headache : Clinical course and treatmentIn: Current Treatment Options in Neurology, Jg. 14, 2012, Nr. 1, S. 15 – 26
-
Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic strokeIn: European Heart Journal, Jg. 33, 2012, Nr. 22, S. 2804 – 2812
-
Integrierte Versorgung Kopfschmerz : Erfahrungen aus Deutschland, Dänemark und den USAIn: Aktuelle Neurologie, Jg. 39, 2012, Nr. 9, S. 467 – 474
-
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran : the RE-LY trialIn: Stroke, Jg. 43, 2012, Nr. 6, S. 1511 – 1517DOI (Open Access)
-
Lateralized central facilitation of trigeminal nociception in cluster headacheIn: Neurology, Jg. 78, 2012, Nr. 13, S. 985 – 992
-
Lokale Therapie des ischämischen Insultes : mechanische ThrombektomieIn: Aktuelle Neurologie, Jg. 39, 2012, Nr. 4, S. 180 – 185
-
Medikamentöse Behandlung der chronischen MigräneIn: Internistische Praxis, Jg. 52, 2012, Nr. 3, S. 583 – 590
-
Migraine and stroke perspectives for stroke physiciansIn: Stroke, Jg. 43, 2012, Nr. 12, S. 3421 – 3426
-
Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillationIn: European Heart Journal, Jg. 33, 2012, Nr. Suppl. 1, S. 815
-
Neue Antikoagulanzien zur Schlaganfallprävention bei VorhofflimmernIn: Herz: Cardiovascular Diseases, Jg. 37, 2012, Nr. 4, S. 370 – 377
-
Neurostimulation zur Behandlung von KopfschmerzenIn: Der Nervenarzt, Jg. 83, 2012, Nr. 8, S. 994 – 1000
-
Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack : A systematic review and meta-analysis of randomized controlled trialsIn: Stroke, Jg. 43, 2012, Nr. 12, S. 3298 – 3304
-
Pain measurement : Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headacheIn: Cephalalgia, Jg. 32, 2012, Nr. 3, S. 185 – 197
-
Posterior reversible encephalopathy syndrome (PRES) : electroencephalographic findings and seizure patternsIn: Journal of Neurology, Jg. 259, 2012, Nr. 7, S. 1383 – 1389
-
Prevalence of primary headaches in Germany : results of the German Headache Consortium StudyIn: The Journal of Headache and Pain, Jg. 13, 2012, Nr. 3, S. 215 – 223
-
Preventing cardioembolic stroke in atrial fibrillation with dabigatranIn: Current Neurology and Neuroscience Reports, Jg. 12, 2012, Nr. 1, S. 17 – 23
-
Randomized comparison of synchronous CABG and carotid endarterectomy vs. isolated CABG in patients with asymptomatic carotid stenosis : the CABACS trialIn: International Journal of Stroke, Jg. 7, 2012, Nr. 4, S. 354 – 360
-
Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial”In: Circulation, Jg. 125, 2012, Nr. 3, S. e293 – e294
-
Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headacheIn: Cephalalgia, Jg. 32, 2012, Nr. 13, S. 953 – 962
-
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudyIn: Stroke, Jg. 43, 2012, Nr. 2, S. 350 – 355
-
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack : A subgroup analysis of ROCKET AFIn: The Lancet Neurology, Jg. 11, 2012, Nr. 4, S. 315 – 322
-
Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patientsIn: International Journal of Stroke, Jg. 7, 2012, Nr. 8, S. 655 – 661
-
Schlaganfall und Herzinfarkt unter der „Pille“?In: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 19, S. 30
-
Schlaganfallprophylaxe bei Vorhofflimmern : Neue orale Antikoagulanzien im Vergleich mit Vitamin-K-AntagonistenIn: Psychopharmakotherapie, Jg. 19, 2012, Nr. 2, S. 43 – 53
-
Schmerzkombis : NachgefragtIn: Pharmazeutische Zeitung online (PZ), Jg. 157, 2012, Nr. 13
-
Schon15 Minuten Bewegung täglich verlängern das LebenIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 5, S. 41
-
Secondary stroke prevention : Patent foramen ovale, aortic plaque, and carotid stenosisIn: European Heart Journal, Jg. 33, 2012, Nr. 6, S. 705 – 713DOI (Open Access)
-
Stroke prevention in atrial fibrillation : Do we still need warfarin?In: Current Opinion in Neurology, Jg. 25, 2012, Nr. 1, S. 27 – 35
-
Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudyIn: Stroke, Jg. 43, 2012, Nr. 9, S. 2336 – 2342DOI (Open Access)
-
The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & RehabilitationIn: European Heart Journal, Jg. 33, 2012, Nr. 17, S. 2126
-
The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors : The Next Diadochian War?In: International Journal of Stroke, Jg. 7, 2012, Nr. 2, S. 139 – 141
-
The VISTA collaboration : exploratory analysis of trial data to inform RCT designIn: European Journal of Neurology, Jg. 19, 2012, Nr. Suppl. 1, S. 147
-
Therapie und Prophylaxe der Migräne : Attacken kupieren und verhindern, dass sie wiederkommenIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 7, S. 52 – 55
-
Therapie und Versorgung bei chronischer Migräne : Expertenempfehlung der Deutschen Migräne- und Kopfschmerzgesellschaft/Deutsche Gesellschaft für Neurologie sowie der Österreichischen Kopfschmerzgesellschaft/Schweizerischen KopfwehgesellschaftIn: Der Nervenarzt, Jg. 83, 2012, Nr. 12, S. 1600 – 1608
-
Vorhofflimmern: Schlaganfallrisiko bei älteren frauen besonders hoch : KommentarIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 17, S. 44
-
Voxel Based Morphometry Showing Acute Alteration in a Visual ParadigmIn: Neurology, Jg. 78, 2012, Nr. Suppl. 1, S. P01.195
-
Why Should American Headache and Migraine Patients Still Be Treated With Butalbital‐Containing Medicine?In: Headache: The Journal of Head and Face Pain, Jg. 52, 2012, Nr. 4, S. 672 – 674
-
Wie entstehen die Leitlinien der Deutschen Gesellschaft für Neurologie?In: Aktuelle Neurologie, Jg. 39, 2012, Nr. 10, S. 525 – 529
-
Wie ist die Prognose bei zerebralen Cavernomen? : KommentarIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. 9, S. 40
-
Wie schreibe ich eine wissenschaftliche Publikation?In: Aktuelle Neurologie, Jg. 39, 2012, Nr. 9, S. 459 – 462
-
Wirken Kortikosteroide beim akuten Hörsturz? : KommentarIn: MMW - Fortschritte der Medizin, Jg. 154, 2012, Nr. Suppl. 3, S. 42
-
"OnabotulinumtoxinA for Treatment of Chronic Migraine" : Author responseIn: Headache: The Journal of Head and Face Pain, Jg. 51, 2011, Nr. 6, S. 1003 – 1005
-
Akuttherapie und Prävention des ischämischen SchlaganfallsIn: Journal fur Neurologie, Neurochirurgie und Psychiatrie, Jg. 12, 2011, Nr. 1, S. 50 – 54
-
Antipsychotische Therapie erhöht das ThromboembolierisikoIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 6, S. 28
-
Antipsychotische Therapie und Risiko venöser ThromboembolienIn: Psychopharmakotherapie, Jg. 18, 2011, Nr. 1, S. 42 – 43
-
Apixaban in patients with atrial fibrillationIn: The New England Journal of Medicine, Jg. 364, 2011, Nr. 9, S. 806 – 817
-
Augenschmerzen aus neurologischer SichtIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 108, 2011, Nr. 12, S. 1120 – 1126
-
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks : results from a phase II studyIn: Cephalalgia, Jg. 31, 2011, Nr. 5, S. 573 – 584
-
Behandlung der chronischen MigräneIn: Arzneimitteltherapie (AMT), Jg. 29, 2011, Nr. 5, S. 149 – 154
-
Beim akuten Hörsturz Kortikoide einfach oral geben : KommentarIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 42, S. 36
-
Chronic Pain, Use of Mixed Analgesics/Opioids and Medication Overuse Are Associated with Chronic Daily Headache : Results of German Headache StudyIn: Neurology, Jg. 76, 2011, Nr. 9 Suppl. 4, S. A35 – A36
-
Chronic migraine : classification and comparisonsIn: Cephalalgia, Jg. 31, 2011, Nr. 5, S. 520 – 529
-
Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: An observational studyIn: The Journal of Headache and Pain, Jg. 12, 2011, Nr. 4, S. 475 – 483DOI (Open Access)
-
Cluster headache : Clinical features and therapeutic optionsIn: Deutsches Ärzteblatt International, Jg. 108, 2011, Nr. 33, S. 543 – 549DOI (Open Access)
-
Comprehensive risk reduction in patients with atrial fibrillation : Emerging diagnostic and therapeutic optionsIn: Thrombosis and Haemostasis, Jg. 106, 2011, Nr. 6, S. 1012 – 1019
-
Course of Disease in Cluster Headache Is Reflected by Distinct Gray Matter TransformationIn: Neurology, Jg. 76, 2011, Nr. 9 Suppl. 4, S. A266
-
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke : a subgroup analysis of the RE-LY trial (vol 9, pg 1157, 2010)In: The Lancet Neurology, Jg. 10, 2011, Nr. 1, S. 27
-
Dabigatran in der Schlaganfallprvention bei Patienten mit Vorhofflimmern nach TIA oder ischmischem Insult : praktische Aspekte der AnwendungIn: Aktuelle Neurologie, Jg. 38, 2011, Nr. 5, S. 261 – 266
-
Dabigatran zur Schlaganfallprävention bei Patienten mit VorhofflimmernIn: Arzneimitteltherapie (AMT), Jg. 29, 2011, Nr. 10, S. 294 – 301
-
Dabigatran zur Schlaganfallprävention bei Patienten mit VorhofflimmernIn: Psychopharmakotherapie, Jg. 18, 2011, Nr. 4, S. 156 – 163
-
Einsatz neuromodulierender Verfahren bei primären Kopfschmerzen : Therapieempfehlungen der Deutschen Migräne- und KopfschmerzgesellschaftIn: Nervenheilkunde, Jg. 30, 2011, Nr. 1-2, S. 47 – 58
-
Evaluating integrated headache care : a one-year follow-up observational study in patients treated at the Essen headache centreIn: BMC Neurology, Jg. 11, 2011, S. 124DOI, Online Volltext (Open Access)
-
Frovatriptan for Prophylactic Treatment of Cluster Headache : Lessons for Future Trial DesignIn: Headache: The Journal of Head and Face Pain, Jg. 51, 2011, Nr. 1, S. 129 – 134
-
Headache attributable to nonvascular intracranial disordersIn: Current Pain and Headache Reports, Jg. 15, 2011, Nr. 4, S. 314 – 323
-
Home time is extended in patients with ischemic stroke who receive thrombolytic therapy : A validation study of home time as an outcome measureIn: Stroke, Jg. 42, 2011, Nr. 4, S. 1046 – 1050
-
Hypothalamic gray matter volume loss in hypnic headacheIn: Annals of Neurology, Jg. 69, 2011, Nr. 3, S. 533 – 539
-
Karotisstenose bei Frauen lieber operieren als stenten?In: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 43, S. 32
-
Level of systolic blood pressure within the normal range and risk of recurrent strokeIn: JAMA: Journal of the American Medical Association, Jg. 306, 2011, Nr. 19, S. 2137 – 2144DOI (Open Access)
-
MTHFR 677C>T polymorphism and cluster headacheIn: Headache: The Journal of Head and Face Pain, Jg. 51, 2011, Nr. 2, S. 201 – 207
-
Migraine and cardiovascular disease in women and the role of aspirin : Subgroup analyses in the Women's Health StudyIn: Cephalalgia, Jg. 31, 2011, Nr. 10, S. 1106 – 1115
-
Migraine, migraine aura, and cervical artery dissection : A systematic review and meta-analysisIn: Cephalalgia, Jg. 31, 2011, Nr. 8, S. 886 – 896
-
Migräne "löchert" die weiße Substanz : KommentarIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 44, S. 33
-
Modulation of human trigeminal and extracranial nociceptive processing by transcranial direct current stimulation of the motor cortexIn: Cephalalgia, Jg. 31, 2011, Nr. 6, S. 661 – 670
-
Neue Antikoagulanzien ab CHADS2 ≥ 1 : VorhofflimmernIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 38, S. 44 – 47
-
Neues zu Kopfschmerzen 2011 : ein UpdateIn: Aktuelle Neurologie, Jg. 38, 2011, Nr. 9, S. 465 – 475
-
Neural substrates of good and poor recovery after hemiplegic stroke : A serial pet studyIn: Journal of Neurology, Jg. 258, 2011, Nr. 12, S. 2168 – 2175
-
Neuromodulative Therapieoptionen beim therapierefraktären chronischen ClusterkopfschmerzIn: Schweizer Archiv für Neurologie und Psychiatrie, Jg. 162, 2011, Nr. 5, S. 198 – 201
-
Nociceptive blink reflex and pain-related evoked potentials in hypnic headacheIn: Cephalalgia, Jg. 31, 2011, Nr. 11, S. 1181 – 1188
-
Obesity and recurrent vascular risk after a recent ischemic strokeIn: Stroke, Jg. 42, 2011, Nr. 12, S. 3397 – 3402
-
Occipital nerve stimulation for the treatment of chronic cluster headache lessons learned from 18 months experienceIn: Central European Neurosurgery, Jg. 72, 2011, Nr. 2, S. 84 – 89
-
OnabotulinumtoxinA for Chronic Migraine : Safety and Efficacy of Fixed-Site, Fixed-Dose Injection Paradigm in PREEMPT Clinical ProgramIn: Neurology, Jg. 76, 2011, Nr. 9 Suppl. 4, S. A267
-
OnabotulinumtoxinA for treatment of chronic migraine: A responseIn: Headache: The Journal of Head and Face Pain, Jg. 51, 2011, Nr. 6, S. 1005 – 1008
-
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraineIn: Neurology, Jg. 77, 2011, Nr. 15, S. 1465 – 1472
-
Partial aortic occlusion for cerebral perfusion augmentation : safety and efficacy of NeuroFlo in Acute Ischemic Stroke trialIn: Stroke, Jg. 42, 2011, Nr. 6, S. 1680 – 1690DOI (Open Access)
-
Perimenstrual migraines and their response to preventive therapy with topiramateIn: Cephalalgia, Jg. 31, 2011, Nr. 2, S. 152 – 160
-
Peripheral nervous system involvement in multiple sclerosisIn: European Journal of Neurology, Jg. 18, 2011, Nr. 5, S. 789 – 791
-
Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: A population-based studyIn: Cephalalgia, Jg. 31, 2011, Nr. 15, S. 1542 – 1548
-
Recurrent Stroke after Lobar and Deep Intracerebral Hemorrhage : A Hospital-Based Cohort StudyIn: Cerebrovascular Diseases, Jg. 32, 2011, Nr. 3, S. 283 – 288
-
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraineIn: The Journal of Headache and Pain, Jg. 12, 2011, Nr. 2, S. 137 – 138DOI (Open Access)
-
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation : an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialIn: Circulation, Jg. 123, 2011, Nr. 21, S. 2363 – 2372
-
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS₂ score : A subgroup analysis of the Re-Ly trialIn: Annals of Internal Medicine, Jg. 155, 2011, Nr. 10, S. 660 – 667
-
Schützen B-Vitamine vor dem zweiten Schlaganfall? : KommentarIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 4, S. 30
-
Schützt ASS Diabetiker vor Schlaganfall und Herzinfarkt? : KommentarIn: MMW - Fortschritte der Medizin, Jg. 153, 2011, Nr. 44, S. 27
-
Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs-is antiplatelet monotherapy still reasonable?In: International Journal of Clinical Practice, Jg. 65, 2011, Nr. 5, S. 531 – 535DOI, Online Volltext (Open Access)
-
Self-medication of migraine and tension-type headache : Summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG)In: The Journal of Headache and Pain, Jg. 12, 2011, Nr. 2, S. 201 – 217DOI (Open Access)
-
Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infectionIn: Journal of Neurology, Jg. 258, 2011, Nr. 1, S. 80 – 88
-
Serial Polysomnography in Cluster Headache Shows No Association with REM SleepIn: Neurology, Jg. 76, 2011, Nr. 9 Suppl. 4, S. A201 – A202
-
The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in Acute Ischemic Stroke : A Randomized, Double-Blind, Placebo-Controlled, Multinational Pivotal Phase III StudyIn: International Journal of Stroke, Jg. 6, 2011, Nr. 4, S. 362 – 367
-
The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache : A post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group studyIn: Cephalalgia, Jg. 31, 2011, Nr. 14, S. 1466 – 1476
-
Treatment costs and indirect costs of cluster headache : a health economics analysisIn: Cephalalgia, Jg. 31, 2011, Nr. 16, S. 1664 – 1672
-
Treatment of chronic migraineIn: Current Pain and Headache Reports, Jg. 15, 2011, Nr. 1, S. 64 – 69
-
Trizyklische Antidepressiva bei chronischem Spannungskopfschmerz und MigräneIn: Psychopharmakotherapie, Jg. 18, 2011, Nr. 1, S. 41 – 42
-
Why do acute ischemic stroke patients with a preceding transient ischemic attack present with less severe strokes? : Insights from the German stroke studyIn: European Neurology, Jg. 66, 2011, Nr. 5, S. 265 – 270
-
5th UK Stroke Forum Conference 30 November-2 December 2010 SECC, Glasgow, UK AbstractsIn: International Journal of Stroke, Jg. 5, 2010, Nr. Suppl. 3, S. 3 – 67
-
Acute treatment of migraine with the selective 5-HT₁F receptor agonist lasmiditan - A randomised proof-of-concept trialIn: Cephalalgia, Jg. 30, 2010, Nr. 10, S. 1170 – 1178
-
Anticoagulation and atrial fibrillationIn: Schweizer Archiv für Neurologie und Psychiatrie, Jg. 161, 2010, Nr. 6, S. 236DOI (Open Access)
-
Antiplatelet therapy in secondary stroke prevention : state of the artIn: Journal of Cellular and Molecular Medicine, Jg. 14, 2010, Nr. 11, S. 2552 – 2560DOI (Open Access)
-
Antithrombotische und Antikoagulanzientherapie nach Schlaganfall und transitorisch ischämischer AttackeIn: Der Nervenarzt, Jg. 81, 2010, Nr. 12, S. 1509 – 1517
-
Asymptomatische carotisstenose: : Bei Mikroembolien ist der Schlaganfall nicht weitIn: MMW - Fortschritte der Medizin, Jg. 152, 2010, Nr. 39, S. 32
-
Beidseitige Nervus-occipitalis-Stimulation zur Behandlung des therapierefraktären chronischen Cluster-Kopfschmerzes : eigene Fallserie und Initiierung einer prospektiven StudieIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 78, 2010, Nr. 12, S. 709 – 714
-
Benzodiazepine können eine Ischialgie nicht lindernIn: MMW - Fortschritte der Medizin, Jg. 152, 2010, Nr. 47, S. 29
-
Cardiological evaluation after cerebral ischaemia : Consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG)In: Clinical Research in Cardiology, Jg. 99, 2010, Nr. 10, S. 609 – 625
-
Clinical characteristics and therapeutic options in hypnic headacheIn: Cephalalgia, Jg. 30, 2010, Nr. 12, S. 1435 – 1442
-
Controversies and future perspectives of antiplatelet therapy in secondary stroke preventionIn: Journal of Cellular and Molecular Medicine, Jg. 14, 2010, Nr. 10, S. 2371 – 2380DOI (Open Access)
-
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF) : Design and rationaleIn: American Heart Journal, Jg. 160, 2010, Nr. 1, S. 36 – 41.e1
-
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke : A subgroup analysis of the RE-LY trialIn: The Lancet Neurology, Jg. 9, 2010, Nr. 12, S. 1157 – 1163
-
Der akute Kopfschmerz : Diagnostisches Vorgehen und Zuordnung der SymptomeIn: Klinikarzt, Jg. 39, 2010, Nr. 9, S. 394 – 397
-
Differences in Chinese diagnoses for migraine and tension-type headache : An analysis of the German acupuncture trials (GERAC) for headacheIn: Cephalalgia, Jg. 30, 2010, Nr. 2, S. 224 – 232
-
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial) : a randomised, open-label, blinded-endpoint trialIn: The Lancet Neurology, Jg. 9, 2010, Nr. 2, S. 159 – 166
-
Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke : PRoFESS subgroup analysisIn: Stroke, Jg. 41, 2010, Nr. 4, S. 732 – 738
-
Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathyIn: European Journal of Neurology, Jg. 17, 2010, Nr. 6, S. 834 – 841
-
Eye-movement training-induced changes of visual field representation in patients with post-stroke hemianopiaIn: Journal of Neurology, Jg. 257, 2010, Nr. 11, S. 1832 – 1840
-
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramateIn: Cephalalgia, Jg. 30, 2010, Nr. 11, S. 1290 – 1295
-
Frühe Sekundärprävention bei TIA und ischämischem Insult mit ThrombozytenfunktionshemmernIn: Aktuelle Neurologie, Jg. 37, 2010, Nr. 10, S. 524 – 529
-
Glatiramerazetat bei Patienten mit klinisch isoliertem MS-typischem Syndrom : PreCISe-StudieIn: Der Internist, Jg. 51, 2010, Nr. 6, S. 793 – 794
-
Guidelines for controlled trials of drugs in tension-type headache : second editionIn: Cephalalgia, Jg. 30, 2010, Nr. 1, S. 1 – 16
-
Incidence and predictors of chronic headache attributed to whiplash injuryIn: Cephalalgia, Jg. 30, 2010, Nr. 5, S. 528 – 534
-
Influence of age on outcome from thrombolysis in acute stroke : A controlled comparison in patients from the virtual international stroke trials archive (VISTA)In: Stroke, Jg. 41, 2010, Nr. 12, S. 2840 – 2848DOI (Open Access)
-
Isolated degeneration of the posterior column as a distinct entity - a clinical and electrophysiologic follow-up studyIn: Clinical Neurology and Neurosurgery, Jg. 112, 2010, Nr. 3, S. 209 – 212
-
Kardiologische Diagnostik nach zerebraler Ischämie : Konsensuspapier der Arbeitsgemeinschaft Herz und Hirn der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK) und der Deutschen Schlaganfallgesellschaft e.V. (DSG)In: Der Nervenarzt, Jg. 81, 2010, Nr. 4, S. 444 – 462
-
Migraines with and without aura and their response to preventive therapy with TopiramateIn: Cephalalgia, Jg. 30, 2010, Nr. 5, S. 543 – 551
-
Neues bei KopfschmerzenIn: Journal fur Neurologie, Neurochirurgie und Psychiatrie, Jg. 11, 2010, Nr. 1, S. 12 – 16Online Volltext (Open Access)
-
OnabotulinumtoxinA Treatment Reduces Headache Duration in Adults with Chronic Migraine : Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical Program
52nd Annual Scientific Meeting of the American Headache Society. June 24-27, 2010. Los Angeles, California, USA,In: Headache: The Journal of Head and Face Pain, Jg. 50, 2010, Nr. Suppl. 1, S. S58 – S59 -
OnabotulinumtoxinA for Treatment of Chronic Migraine : Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical ProgramIn: Neurology, Jg. 74, 2010, Nr. 9 Suppl. 2, S. A281
-
OnabotulinumtoxinA for treatment of chronic migraine : Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical programIn: Headache: The Journal of Head and Face Pain, Jg. 50, 2010, Nr. 6, S. 921 – 936
-
OnabotulinumtoxinA for treatment of chronic migraine : results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialIn: Cephalalgia, Jg. 30, 2010, Nr. 7, S. 793 – 803
-
OnabotulinumtoxinA for treatment of chronic migraine : Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trialIn: Cephalalgia, Jg. 30, 2010, Nr. 7, S. 804 – 814
-
Placebo effects in treating migraine and other headachesIn: Current Opinion in Investigational Drugs, Jg. 11, 2010, Nr. 7, S. 735 – 739
-
Post-traumatic headache: Is it for real? Crossfire debates on headache: ProIn: Headache: The Journal of Head and Face Pain, Jg. 50, 2010, Nr. 4, S. 710 – 715
-
Prediction of Recurrent Stroke and Vascular Death in Patients with Transient Ischemic Attack or Nondisabling Stroke : A Prospective Comparison of Validated Prognostic ScoresIn: Stroke, Jg. 41, 2010, Nr. 3, S. 487 – 493DOI, Online Volltext (Open Access)
-
Prevalence of facial pain in migraine : A population-based studyIn: Cephalalgia, Jg. 30, 2010, Nr. 1, S. 92 – 96
-
Prevention of cardioembolic stroke in patients with atrial fibrillationIn: Expert Review of Cardiovascular Therapy, Jg. 8, 2010, Nr. 10, S. 1405 – 1415
-
Prevention of medication overuse in patients with migraineIn: Pain, Jg. 151, 2010, Nr. 2, S. 404 – 413
-
Primary and secondary prevention of cerebral ischemia : Joint Guidelines of the German Society of Neurology (DGN) and German Stroke Society (DSG)In: Aktuelle Neurologie, Jg. 37, 2010, Nr. 4, S. E2 – E22
-
Questions on surgical treatment of migraineIn: Plastic and Reconstructive Surgery, Jg. 126, 2010, Nr. 2, S. 669 – 690
-
Rationale and design of interstroke : A global case-control study of risk factors for strokeIn: Neuroepidemiology, Jg. 35, 2010, Nr. 1, S. 36 – 44
-
Recurrent stroke after cervical artery dissectionIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 81, 2010, Nr. 8, S. 869 – 873
-
Reduced Cerebral Bleeding Rates with Dabigatran Compared to Warfarin in Patients with Atrial Fibrillation : Results of RE-LYIn: Neurology, Jg. 74, 2010, Nr. 9 Suppl., S. A281
-
Reply: Randomized, Controlled Trial of Telcagepant for teh acute Treatment of MigraineIn: Neurology, Jg. 74, 2010, Nr. 12, S. 1007 – 1008
-
Response from the authors to: Identification of paroxysmal atrial fibrillation also for primary prevention of embolic strokeIn: American Heart Journal, Jg. 160, 2010, Nr. 6, S. E45
-
Restless-Legs-Syndrom : Besänftigt ein Antikonvulsivum die Beine?In: MMW - Fortschritte der Medizin, Jg. 152, 2010, Nr. 40, S. 31
-
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study) : A case-control studyIn: Lancet, Jg. 376, 2010, Nr. 9735, S. 112 – 123
-
Sensory Neuropathy in Patients with Cryoglobulin Negative Hepatitis-C InfectionIn: Neurology, Jg. 74, 2010, Nr. 9 Suppl. 2, S. A519 – A520
-
Sensory disinhibition on passive movement in cervical dystoniaIn: Movement Disorders, Jg. 25, 2010, Nr. 15, S. 2627 – 2633
-
Serial Polysomnography in Hypnic Headache Shows No Association with REM SleepIn: Neurology, Jg. 74, 2010, Nr. 9 Suppl. 2, S. A576
-
Single nucleotide polymorphisms of the serotonin transporter gene in migraine-an association study : Clinical notesIn: Headache: The Journal of Head and Face Pain, Jg. 50, 2010, Nr. 2, S. 319 – 322
-
Single-pulse transcranial magnetic stimulation : a new way to treat migraine attacks with auraIn: The Lancet Neurology, Jg. 9, 2010, Nr. 4, S. 335 – 337
-
Stellenwert der " Migränechirurgie" : Übersicht über das pathophysiologische Konzept und die aktuelle DatenlageIn: Der Nervenarzt, Jg. 81, 2010, Nr. 4, S. 463 – 470
-
Symptomatic intracranial atherosclerotic stenoses : Prevalence and prognosis in patients with acute cerebral ischemiaIn: Cerebrovascular Diseases, Jg. 30, 2010, Nr. 2, S. 188 – 193
-
The virtual international stroke trials archive (vista) : Results and impact on future stroke trials and management of stroke patientsIn: International Journal of Stroke, Jg. 5, 2010, Nr. 2, S. 103 – 109
-
Thrombolysis is Associated With Improved Outcome in Elderly Stroke Patients : A Non-randomized Comparison of Outcomes Amongst Patients From the Virtual International Stroke Trials Archive (VISTA)In: Stroke, Jg. 41, 2010, Nr. 4, S. E208 – E209
-
Tiefe Hirnstimulation in der Neurologie – Indikationen und ErgebnisseIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 78, 2010, Nr. 2, S. 107 – 117
-
Was gibt es Neues beim Schlaganfall?In: Arzneimitteltherapie (AMT), Jg. 28, 2010, Nr. 12, S. 371 – 380
-
Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of Cisplatin-induced neuropathyIn: BMC Neuroscience, Jg. 10, 2009, 77DOI (Open Access)
-
Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapyIn: Neuroscience letters, Jg. 441, 2008, Nr. 1, S. 39 – 43
-
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeIn: The New England Journal of Medicine, Jg. 359, 2008, Nr. 12, S. 1238 – 1251DOI (Open Access)
-
Cognitive Outcomes Three Years After Coronary Artery Bypass Surgery : Relation to Diffusion-Weighted Magnetic Resonance ImagingIn: The Annals of Thoracic Surgery, Jg. 85, 2008, Nr. 3, S. 872 – 879
-
Telmisartan to prevent recurrent stroke and cardiovascular eventsIn: The New England Journal of Medicine, Jg. 359, 2008, Nr. 12, S. 1225 – 1237DOI (Open Access)
-
Development and validation of the Essen Intracerebral Haemorrhage ScoreIn: Journal of Neurology, Neurosurgery and Psychiatry, Jg. 77, 2006, Nr. 5, S. 601 – 605DOI (Open Access)
-
Prevalences of primary headache symptoms at school-entry : A population-based epidemiological survey of preschool children in GermanyIn: Journal of Headache and Pain, Jg. 7, 2006, Nr. 5, S. 331 – 340
-
Lack of neuroprotection by an ACTH (4-9) analogue : A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaIn: Journal of Cancer Research and Clinical Oncology, Jg. 130, 2004, Nr. 3, S. 153 – 160
-
Neues zur Epidemiologie von KopfschmerzenIn: Fortschritte der Neurologie - Psychiatrie (FDN), Jg. 72, 2004, Nr. 4, S. 184 – 191
-
Oh, Schmerz lass nach? : Kopfschmerzforschung in EssenIn: Essener Unikate: Berichte aus Forschung und Lehre, 2003, Nr. 22 : Neurowissenschaften – Wir und unser Gehirn, S. 60 – 67Online Volltext, Online Volltext (Open Access)
-
Pioniere der „Stroke Units" : Schlaganfallforschung in EssenIn: Essener Unikate: Berichte aus Forschung und Lehre, 2003, Nr. 22 : Neurowissenschaften – Wir und unser Gehirn, S. 50 – 59Online Volltext, Online Volltext (Open Access)
-
New migraine drugsIn: Cephalalgia. London: Sage Publications, Jg. 43, 2023, Nr. 3DOI (Open Access)
-
Herz und Hirn – zwei Begriffe, ein zentrales Problem : Der SchlaganfallIn: Herz: Cardiovascular Diseases. Berlin: Springer Nature, Jg. 44, 2019, Nr. 4, S. 287 – 288DOI, Online Volltext (Open Access)
-
Fake Science, Fake Kongresse und Open-Access-JournaleIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 45, 2018, Nr. 7, S. 511 – 512
-
Cerebellar Function and MigraineIn: Cephalalgia. London: Sage Publications, Jg. 37, 2017, Nr. 2, S. 103
-
Der industriefreie DGN-Kongress : Der Veggie Day für die Deutsche NeurologieIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 44, 2017, Nr. 9, S. 600 – 601
-
Does atrial fibrillation lead to cognitive decline and dementia?In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 38, 2017, Nr. 34, S. 2619 – 2620
-
Neues zum Schlaganfall : ESOC 2017In: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 44, 2017, Nr. 6, S. 379 – 380
-
Wissenschaftlicher Betrug : neue Nachweismethoden?In: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 44, 2017, Nr. 2, S. 81
-
Das Arztbild in der Öffentlichkeit : Es wird Zeit, dass wir uns wehrenIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 40, 2013, Nr. 7, S. 366
-
Devices vs. Medikamente : Wann kommt endlich die Waffengleichheit?In: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 40, 2013, Nr. 6, S. 305 – 306
-
Foreword: Novel approaches in migraine treatmentIn: Novel Approaches in Migraine Treatment / Diener, Hans Christoph. London: Future Medicine Ltd., 2013, S. 3 – 5
-
More patients with atrial fibrillation need to be anticoagulatedIn: European Journal of Neurology. Hoboken: Wiley, Jg. 20, 2013, Nr. 4, S. 597 – 598
-
Secondary prevention by stroke subtype : Impact of the Korean experienceIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 34, 2013, Nr. 35, S. 2723 – 2724
-
Das Arbeitszeitgesetz : Empirie versus IdeologieIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 39, 2012, Nr. 6, S. 273
-
Occipital nerve stimulation for chronic migraine : Already advised?In: Cephalalgia. London: Sage Publications, Jg. 32, 2012, Nr. 16, S. 1163 – 1164
-
Triptans for migraineIn: Triptans for Migraine / Dodick, David W.; Diener, Hans Christoph (Hrsg.). London: Future Medicine, 2012, S. 3 – 4
-
Prevention of dementia should start 20 years before symptoms become apparentIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 32, 2011, Nr. 18, S. 2228 – 2230DOI (Open Access)
-
Schlaganfall in der Neurologie : Eine Erfolgsgeschichte die Ihresgleichen sucht
3. Deutscher Botulinumtoxin-Kongress Wiesbaden, 6.–7. Mai 2011,In: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 38, 2011, Nr. 2, S. 57 -
10 Jahre Berufsverband der NeurologenIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 37, 2010, Nr. 2, S. 68
-
Hygieneskandal in Mainz: Wo bleibt die Entschuldigung?In: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 37, 2010, Nr. 7, S. 315
-
Is migraine a dangerous disease?In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 74, 2010, Nr. 8, S. 622 – 623
-
Leitlinien: wer bestellt bezahltIn: Aktuelle Neurologie. Stuttgart: Thieme, Jg. 37, 2010, Nr. 9, S. 437
-
Determinants of 90-Day Cognitive Performance after Acute Ischemic Stroke : A Secondary Analysis of the Axiomatic-SSP TrialIn: European Respiratory Journal (ERJ). Sheffield: European Respiratory Society, Jg. 19, 2024, Nr. Suppl. 2, S. 30 – 31
-
Efficacy and Safety of Anticoagulation with Edoxaban in Patients With AHRE Durations ≥24 Hours : The NOAH-AFNET 6 Trial
Resuscitation Science Symposium 2023, November 11 -12, 2023, Philadelphia, PE, USA,In: Circulation. Baltimore; New York, NY; Dallas: American Heart Association, Jg. 148, 2024, Nr. 25, S. E289 – E290 -
Preventive Treatment With Eptinezumab in Patients With a Dual Diagnosis of Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2
American Academy of Neurology: Annual Meeting, 22.-27.04.2023, Boston,In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 100, 2023, Nr. 17, Supplement 2, (S47.006) -
CO157 Reductions in Acute Headache Medication Use after Eptinezumab Treatment in Patients with Chronic Migraines and Medication-Overuse Headache : Exploratory Analysis of PROMISE-2
ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems, 15.-18.05.2022, Virtual,In: Value in Health. New York; Malden, Mass.: Elsevier, Jg. 25, 2022, Nr. 7, Supplement: The Future of HEOR in Patient-Driven Digital Healthcare Systems, S. 333 – S334DOI (Open Access) -
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine : A Pooled PREEMPT AnalysisIn: Toxicon. Amsterdam: Elsevier, Jg. 214, 2022, Nr. Suppl. 1, S. 15 – S16
-
Early Rhythm-Control Therapy for Atrial Fibrillation in Patient with History of Stroke in the East-Afnet 4 Trial
14th World Stroke Congress, 26-29 October 2022, Singapore,In: International Journal of Stroke. London: Sage Publications, Jg. 17, 2022, Nr. 3_Supplement: 14th World Stroke Congress, Singapore, 26-29 October 2022, S. 298 – 290 -
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine : A Pooled PREEMPT AnalysisIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 22, 2021, Nr. Suppl. 1, S. 105
-
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine : A Pooled PREEMPT AnalysisIn: Cephalalgia. London: Sage Publications, Jg. 41, 2021, Nr. Suppl. 1, 115415(Open Access)
-
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine : A Pooled PREEMPT AnalysisIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 96, 2021, Nr. Suppl. 15, 1841
-
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis (1841)In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 96, 2021, Nr. 15 Supplement, 1841
-
Consecutive Migraine-free Days with Fremanezumab Treatment : Results of the Double-blind, Placebo-controlled FOCUS StudyIn: Cephalalgia. London: Sage Publications, Jg. 41, 2021, Nr. Suppl. 1, 115415(Open Access)
-
Consecutive Migraine-free Days with Fremanezumab Treatment : Results of the Double-blind, Placebo-controlled FOCUS StudyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 22, 2021, Nr. 1, S. 51
-
Efficacy in Patients Switching from Quarterly to Monthly Fremanezumab or Maintained on Monthly Fremanezumab Treatment Over 6 Months in the Phase 3b FOCUS StudyIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 96, 2021, Nr. Suppl. 15, 2124
-
Number Needed to Treat/Harm for Fremanezumab in Patients Who Had Inadequate Response to 2-4 Prior Migraine Preventive Medication ClassesIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 96, 2021, Nr. Suppl. 15, 2055
-
COVID-19 : patients with stroke or risk of strokeIn: European Heart Journal Supplements. Oxford; Amsterdam: Oxford University Press, Jg. 22, 2020, Nr. Supplement_P: Cardiovascular Care - Moving forward after COVID-19, S. P25 – P28DOI (Open Access)
-
Efficacy and Safety of Fremanezumab in Patients with Episodic and Chronic Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Medications during the Open Label Period of the Phase 3b FOCUS Study
145th Annual Meeting American Neurological Association ; October 4-9, 2020, Virtual Meeting,In: Annals of Neurology. Hoboken: Wiley, Jg. 88, 2020, Nr. S25, S. S158DOI (Open Access) -
Efficacy in patients switching from quarterly to monthly fremanezumab or maintained on monthly fremanezumab treatment over 6 months in the phase 3B focus studyIn: Cephalalgia. London: Sage Publications, Jg. 40, 2020, Nr. Suppl. 1, S. 83 – 84(Open Access)
-
Number needed to treat/harm for fremanezumab in patients who had inadequate response to 2-4 prior migraine preventive medication classesIn: Cephalalgia. London: Sage Publications, Jg. 40, 2020, Nr. Suppl. 1, S. 102(Open Access)
-
Patient perceptions of the impact and burden of migraine : An international survey of 12,545 patients across 16 countriesIn: Cephalalgia. London: Sage Publications, Jg. 40, 2020, Nr. Suppl. 1, S. 99(Open Access)
-
Sustained clinical benefits following onabotulinumtoxina treatment in patients with chronic migraine : A post hoc analysis of the pooled preempt studiesIn: Cephalalgia. London: Sage Publications, Jg. 40, 2020, Nr. Suppl. 1, S. 92 – 93(Open Access)
-
Odds ratios for response to fremanezumab in migraine patients with inadequate response TO 2-4 migraine preventive medication classes : Results of the focus phase 3B studyIn: Journal of the Neurological Sciences. Amsterdam: Elsevier, Jg. 405, 2019, Nr. Supplement, S. 64 – 65
-
A multicentre, double-blind, randomised, sham-controlled study of non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine : the PREMIUM trialIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 117DOI (Open Access)
-
Beyond the headache phase of a migraine attack : closer look at the burden of migraine phases - results from the worldwide My Migraine Voice survey
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 90 – 91DOI (Open Access) -
Beyond the headache phase of a migraine attack : closer look at the burden of migraine phases - results from the worldwide My Migraine Voice surveyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 75DOI (Open Access)
-
Chronic and Primary Daily Vestibular Migraine - Two New Subtypes of the DisorderIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 90, 2018, Nr. Suppl. 15
-
Dabigatran vs. Acetylsalicylic Acid For Stroke Prevention In Patients With Embolic Stroke Of Undetermined Source (Re-spect Esus) : Arrhythmia Monitoring And Outcomes
American Heart Association’s Scientific Sessions 2018,In: Circulation. Baltimore; New York, NY; Dallas: American Heart Association, Jg. 138, 2018, Nr. 25, S. E768DOI (Open Access) -
Economic burden of migraine : healthcare resource utilization in the My Migraine, Voice surveyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 53DOI (Open Access)
-
Economic burden of migraine : healthcare resource utilization in the My Migraine, Voice survey
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 69 – 70DOI (Open Access) -
Idarucizumab in cerebral ischemia or intracranial hemorrhage under Dabigatran therapy in Germany - a nationwide case collectionIn: European Journal of Neurology. Hoboken: Wiley, Jg. 25, 2018, Nr. Suppl. 2, S. 38DOI (Open Access)
-
Living with migraine : a report from the My Migraine Voice surveyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 94DOI (Open Access)
-
Living with migraine : a report from the My Migraine Voice survey
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 53 – 54DOI (Open Access) -
My Migraine Voice : a worldwide survey of 11,266 migraine patients
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 66DOI (Open Access) -
Non-invasive Vagus Nerve Stimulation (nVNS) for the Preventive Treatment of Episodic Migraine : The Multicentre, Double-Blind, Randomised, Sham-Controlled PREMIUM Trial
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 58 – 59DOI (Open Access) -
P2896 Two-year outcomes of dabigatran etexilate in patients with atrial fibrillation with and without a history of coronary artery disease : data from GLORIA-AF
ESC Congress 2018 25 - 29 August Munich, Germany,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 39, 2018, Nr. suppl_1, S. 610 – 610 -
Randomized controlled trial of the safety and effiacy of dabigatran etexilate vs. dose-adjusted warfarin in patients with cerebral venous thrombosis (Re-spect CVT)In: International Journal of Stroke. London: Sage Publications, Jg. 13, 2018, Nr. 2_Suppl., S. 27DOI (Open Access)
-
Re-spect Esus : Dabigratan versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined sourceIn: International Journal of Stroke. London: Sage Publications, Jg. 13, 2018, Nr. 2_Suppl., S. 27DOI (Open Access)
-
Safety and effectiveness of Dabigatran in patients with atrial fibrillation with and without prior stroke : Data from the Gloria-AF Registry ProgramIn: International Journal of Stroke. London: Sage Publications, Jg. 13, 2018, Nr. 2_Suppl., S. 99DOI (Open Access)
-
Sphenopalatine Ganglion Stimulation to Augment Collateral Perfusion Primary in Acute Ischemic Stroke : Primary Results of the IMPACT-24B Pivotal TrialIn: International Journal of Stroke. London: Sage Publications, Jg. 13, 2018, Nr. 2_Suppl., S. 28DOI (Open Access)
-
Vestibular Perceptual Threshold and Motion Sensitivity in Vestibular Migraine and Persistent Postural-Perceptual DizzinessIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 90, 2018, Nr. Suppl. 15
-
Work Productivity Amongst Those with Migraine : Results from the My Migraine Voice Survey
60th Annual Scientific Meeting American Headache Society June 28–July 1, 2018, San Francisco, USA,In: Headache: The Journal of Head and Face Pain. Hoboken: Wiley-Blackwell - STM, Jg. 58, 2018, Nr. 8, S. 1318 – 1319DOI (Open Access) -
Work Productivity Amongst Those with Migraine : Results from the My Migraine Voice Survey
17th Biennial Migraine Trust International Symposium; 6–9 September 2018; London, UK,In: Cephalalgia. London: Sage Publications, Jg. 38, 2018, Nr. Supplement 1, S. 66 – 68DOI (Open Access) -
Work productivity amongst those with migraine : results from the My Migraine Voice surveyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 50DOI (Open Access)
-
Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation : findings from the GLORIA-AF registry programIn: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 37, 2016, Nr. Suppl. 1, S. 1192 – 1193
-
Use of aspirin combinations with caffeine and increasing headache frequency : a prospective population-based study
International Headache Congress 2015, IHC 2015, 14-17 May 2015, Valencia, Spain,In: Cephalalgia. London: Sage Publications, Jg. 35, 2015, Nr. Suppl. 6, S. 155 -
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgia
Joint Congress of European Neurology 31 May–3 June 2014 Istanbul, Turkey,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 261, 2014, Nr. Suppl.1, S. 39 -
Anodal transcranial direct current stimulation alleviates pain in trigeminal neuralgia
Joint Congress of European Neurology, Istanbul, Turkey, May 2014,In: European Journal of Neurology. Hoboken: Wiley, Jg. 21, 2014, Nr. Suppl. 1, S. 52 -
Antithrombotic treatment pattern and baseline characteristics of dabigatran and vitamin K antagonist cohorts in North America : The GLORIA-AF registry program
ESC Congress 2014, Barcelona, Spain, 30 August – 3 September 2014,In: European Heart Journal. Oxford: Oxford University Press (OUP), Jg. 35, 2014, Nr. Suppl. 1, S. 777 -
Efficacy and safety of occipital nerve blocks in cluster headache : a prospective observational studyIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 14, 2013, Nr. Supplement 1, S. P60DOI (Open Access)
-
Indirect comparison of efficacy and safety of dabigatrans RE-LY, rivaroxabans rocket-AF, and Apixabans Aristotle trial in patients with non-valvular atrial fibrillationIn: Journal of Thrombosis and Haemostasis. Amsterdam: Elsevier, Jg. 11, 2013, Nr. s3, S. 6
-
Novel Anticoagulants in Secondary Stroke Prevention after TIA or Minor Stroke in Patients with Atrial FibrillationIn: Cerebrovascular Diseases. Basel: Karger, Jg. 36, 2013, Nr. Supplement 2, S. 8
-
OnabotulinumtoxinA for chronic migraine treatment : 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPTIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 14, 2013, Nr. Suppl. 1, S. P197DOI (Open Access)
-
OnabotulinumtoxinA for treatment of chronic migraine : Pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical programIn: Toxicon. Amsterdam: Elsevier, Jg. 68, 2013, S. 110
-
OnabotulinumtoxinA for treatment of chronic migraine : PREEMPT 24-week pooled subgroup analysis of patients without medication overuseIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 14, 2013, Nr. Suppl. 1, S. P204DOI (Open Access)
-
Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysisIn: Thrombosis Research, Jg. 130, 2012, S. S100 – S101
-
AVERROES : Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes
International Stroke Conference Oral Presentations,In: Stroke. Philadelphia; New York, NY [u.a.]: Lippincott Williams & Wilkins, Jg. 42, 2011, Nr. 3, S. E81 -
Association of chronic migraine (CM) and chronic back and facial pain : Results of the German Headache Consortium (GHC) study
15th Congress of the European Federation of Neurological Societies (EFNS). September 11-13, 2011. Budapest, Hungary,In: European Journal of Neurology. Hoboken: Wiley, Jg. 18, 2011, Nr. Suppl. 2, S. 23 -
Course of disease in cluster headache is reflected by distinct grey matter transformation
21st Meeting of the European Neurological Society, 28–31 May, 2011, Lisbon, Portugal,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 258, 2011, Nr. Suppl. 1, S. S273 -
Dabigatran versus Warfarin and Impact of CHAD2-VASC score on outcome in Aterial Fibrillation Patients : a Re-Ly Subgroup Anaysis
ACC.11 - American College of Cardiology 60th Annual Scientific Session & Expo, 2-5 April 2011, New Orleans,In: Journal of the American College of Cardiology (JACC). Amsterdam: Elsevier, Jg. 57, 2011, Nr. 14, Supplement, S. E7 -
Home Time Is Extended In Ischemic Stroke Patients Who Receive Thrombolytic Therapy : A Validation Study Of Home Time As An Outcome Measure
International Stroke Conference and Nursing SymposiumPoster Presentations,In: Stroke. Philadelphia; New York, NY [u.a.]: Lippincott Williams & Wilkins, Jg. 42, 2011, Nr. 3, S. E245 – E246 -
Increased frequency of stroke and white matter Hyperintensities in Migraine
15th Congress of the European Federation of Neurological Societies (EFNS). September 11-13, 2011. Budapest, Hungary,In: European Journal of Neurology. Hoboken: Wiley, Jg. 18, 2011, Nr. Suppl. 2, S. 3 -
Lateralized central facilitation of trigeminal nociception in cluster headache
Twenty-first Meeting of the European Neurological Society 28–31 May, 2011,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 258, 2011, Nr. Suppl. 1, S. 31 – 32 -
Onabotulinumtoxin - a for Treatment of Chronic Migraine : Preempt 24-Week pooled subgroup analysis of Patients without Medication overuse
15th Congress of the European Federation of Neurological Societies (EFNS). September 11-13, 2011. Budapest, Hungary,In: European Journal of Neurology. Hoboken: Wiley, Jg. 18, 2011, Nr. Suppl. 2, S. 191 -
Serial polysomnography in cluster headache shows no association with REM sleep
Twenty-first Meeting of the European Neurological Society 28–31 May, 2011,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 258, 2011, Nr. Suppl. 1, S. 56 -
Dabigatran compared to warfarin in patients with atrial fibrillation and prior TIA or stroke : the RE-LY study
Twentieth Meeting of the European Neurological Society 19–23 June 2010 Berlin, Germany,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 257, 2010, Nr. Suppl. 1, S. 31 -
Effect of Combined Aspirin and Extended-release Dipyridamole versus Clopidogrel on Functional Outcome and Recurrence in Patients With Acute Ischaemic Stroke : A PRoFESS Subgroup AnalysisIn: Stroke. Philadelphia; New York, NY [u.a.]: Lippincott Williams & Wilkins, Jg. 41, 2010, Nr. 4, S. E262 – E262
-
Field Testing Chronic Migraine Criteria in the Population : Results of the German Headache Consortium (GHC) StudyIn: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 74, 2010, Nr. 9 Suppl. 2, S. A582
-
OnabotulinumtoxinA Treatment Improves Quality of Life in Patients with Chronic Migraine (CM) : MSQ Results from PREEMPT
52nd Annual Scientific Meeting of the American Headache Society. June 24-27, 2010. Los Angeles, California, USA,In: Headache: The Journal of Head and Face Pain. Hoboken: Wiley-Blackwell - STM, Jg. 50, 2010, Nr. Suppl. 1, S. S30 – S31 -
Serial polysomnography in hypnic headache shows no association with REM sleep
Twenty-first Meeting of the European Neurological Society 28–31 May, 2011,In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 257, 2010, Nr. Suppl. 1, S. 97 – S98 -
Single Nucleotide Polymorphisms of the ADRB2 Gene Modulate Migraine Phenotypes
62nd Annual Meeting of the American Academy of Neurology, April 10 - 17, 2010, Toronto, Ontario, Canada,In: Neurology. Minneapolis; Hagerstown, Md.: American Academy of Neurology, Jg. 74, 2010, Nr. 9 Suppl. 2, S. A2 -
Chronic migraine and medication overuseIn: Migraine Biology, Diagnosis, and Co-Morbidities / Swanson, Jerry W.; Matharu, Manjit (Hrsg.). Amsterdam: Elsevier, 2023, S. 187 – 200
-
Migraine and StrokeIn: Stroke: Pathophysiology, Diagnosis, and Management / Grotta, James C.; Albers, Gregory W.; Broderick, Joseph; Day, Arthur L.; Kasner, Scott E.; Lo, Eng H.; Sacco, Ralph L.; Wong, Ka Sing Lawrence. Philadelphia: Elsevier, 2022, S. 604 – 614.e4
-
Medication Overuse in Chronic Daily HeadacheIn: Medication Overuse in Chronic Daily Headache. Cham: Springer International Publishing, 2018, S. 195 – 206
-
Migraine and StrokeIn: Stroke: Pathophysiology, Diagnosis, and Management / Grotta, James C.. [St. Louis, Mo.]: Elsevier Inc., 2016, S. 695 – 706
-
Drug Treatment for Chronic MigraineIn: Pharmacological Management of Headaches / Mitsikostas, Dimos; Paemeleire, Koen (Hrsg.). Cham: Springer International Publishing, 2015, S. 81 – 87
-
Acute Treatments for MigraineIn: Headache / Robbins, Matthew; Grosberg, Brian M.; Lipton, Richard (Hrsg.). New York, NY: Wiley, J, 2013, S. 113 – 124
-
LasmiditanIn: Novel Approaches in Migraine Treatment / Diener, Hans Christoph. London: Future Medicine Ltd., 2013, S. 37 – 45
-
Patent foramen ovale closureIn: Novel Approaches in Migraine Treatment / Diener, Hans Christoph. London: Future Medicine Ltd., 2013, S. 81 – 90
-
Transient Headache and CSF LymphocytosisIn: Encyclopedia of Pain / Gebhart, Gerald F.; Schmidt, Robert F. (Hrsg.). Berlin: Springer Science+Business Media, 2013, S. 4035 – 4037
-
Antiplatelet therapy in cerebrovascular disordersIn: Antiplatelet Agents / Gresele, Paolo. Heidelberg: Springer, 2012, S. 519 – 546
-
Cerebellar ataxiaIn: Stroke Syndromes / Caplan, Louis R.; Gijn, Jan van (Hrsg.). Cambridge: Cambridge University Press, 2012, S. 21 – 31
-
Treatment recommendations & consensus guidelinesIn: Triptans for Migraine / Dodick, David W .; Diener, Hans Christoph (Hrsg.). London: Future Medicine, 2012, S. 89 – 94
-
Migraine and StrokeIn: Comorbidity in Migraine / Schoenen, Jean; Dodick, David; Sandor, Peter Stephan. Chichester [u.a.]: Wiley-Blackwell, 2011, S. 14 – 26
-
Migraine and StrokeIn: Stroke: Pathophysiology, Diagnosis, and Management / Mohr, J. P.. Philadelphia, Pa.: Elsevier Inc., 2011, S. 720 – 733
-
Headache attributed to a substance or its withdrawalIn: Headache / Aminoff, Michael J.; Boller, François; Swaab, Dick F. (Hrsg.). Amsterdam: Elsevier, 2010, S. 589 – 599
-
Headache attributed to non-vascular intracranial disorderIn: Headache / Aminoff, Michael J.; Boller, François; Swaab, Dick F. (Hrsg.). Amsterdam: Elsevier, 2010, S. 547 – 587
-
Paroxysmal headachesIn: The Paroxysmal Disorders / Schmitz, Bettina; Tettenborn, Barbara; Schomer, Donald L. (Hrsg.). Cambridge: Cambridge University Press, 2010, S. 45 – 55
-
Novel approaches in migraine treatmentLondon: Future Medicine, 2013
-
Facharztprüfung Neurologie : 1000 kommentierte PrüfungsfragenStuttgart: Thieme, 2007
-
My Migraine Voice : a worldwide survey of 11,266 migraine patientsIn: The Journal of Headache and Pain. London: BioMed Central, Jg. 19, 2018, Nr. Suppl. 1, S. 52DOI (Open Access)
-
Migräne und Co : Was tun, wenn der Kopf schmerzt?
Die kleine Form, 28. Juni 2017, Essen,2017(Die kleine Form 2017)